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Chapter One: Background & Significance  
 
Stigma associated with HIV/AIDS is recognized as a significant barrier to the success of 
all aspects of HIV-related interventions globally. The damaging effects of stigma have been 
noted at structural levels in terms of punitive governmental policies and healthcare practices, and 
at the individual level, impacting HIV testing, mental health, antiretroviral treatment adherence, 
and the willingness to disclose HIV status.  
Manifestations of stigma are often unique to specific social or cultural settings, such that 
differences in defining, measuring, and modeling stigma abound in the existing literature, 
resulting in the identification of many different types and categories of stigma in the context of 
HIV/AIDS. The broadest division of stigma is “Internal” (self-blame and guilt for one’s HIV 
status) and “External” (discriminatory behaviors from other people or institutions toward HIV 
positive individuals), with many gradations between the two.  
The aim of this thesis is to investigate the systemic, social, and behavioral correlates of 
“Internalized” stigma among HIV-positive adult men living in major urban centers in the State of 
Maharashtra, India using a mixed-method approach. All of the qualitative and quantitative data 
were gathered through an existing Indo-US, transdisciplinary research and intervention project 
entitled “Alcohol and ART Adherence: Assessment, Intervention and Modeling in India” (2014-
2019; U01AA021990-01; S. Schensul, J. Schensul, N. Saggurti, A. Sarna, MPIs). The objectives 
of this thesis are to provide improve the approaches to characterize and measure Internal Stigma 
in the Indian context, identify the factors associated with greater or lesser internal stigma, and to 
build on existing approaches for reducing stigma through multi-level interventions.  
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Global Epidemiology of HIV/AIDS 
Ahead of both tuberculosis and malaria, Human Immunodeficiency Virus (HIV) is the 
deadliest of the “Big Three” single-agent infectious diseases. HIV affects approximately 36.9 
million people globally and claimed the lives of approximately 1.2 million people in 2014. Many 
of these deaths were the result of complications from Acquired Immune Deficiency Syndrome 
(AIDS), a condition caused by unmanaged infection with HIV (Bourzac, 2014; World Health 
Organization [WHO], 2015). HIV is an ongoing pandemic of the highest public health concern, 
with an approximate incidence of two million new cases diagnosed worldwide in 2014 (Joint 
United Nations Programme on HIV/AIDS [UNAIDS], 2015a).  
HIV infection is found in all regions of the world, yet the distribution of its burden is 
unequal. The great majority of HIV burden exists in Sub-Saharan Africa, carrying about 70% of 
all new cases, 65% of all deaths resulting from HIV complications, and a regional adult 
prevalence of around 5% (UNAIDS, 2015a). At the end of 2013, Sub-Saharan Africa was home 
to approximately 24.7 million people living with HIV (PLHIV). In the same year, the second 
highest global burden was in in the Asia/Pacific region, with an estimated 4.8 million PLHIV 
(UNAIDS, 2014b). Globally, women represent about 47% of all PLHIV, and children under the 
age of 15 account for 2.6 million, or about 7%, of known cases (UNAIDS, 2015a). 
The primary groups of people most at risk of acquiring infection due to lifestyle 
exposures and disproportionally high rates of in-group seroprevalence are men who have sex 
with men (MSM), injection drug users (IDU), transgender people, and commercial sex workers 
(CSW). Unprotected heterosexual sex remains the principal transmission pathway in Sub-
Saharan Africa and other areas, particularly in the context of long-term relationships (Fettig, 
Swaminathan, Murrill, & Kaplan, 2014).  
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Transmission of HIV is greatly enhanced when there are higher concentrations of the 
virus in the body, measured by “viral load.” The risk of transmission also greatly increases when 
there is co-infection with other sexually transmitted infections (STIs), particularly with herpes 
simplex virus, bacterial vaginosis, or the presence of any type of open genital ulcer (Maartens, 
Celum, & Lewin, 2014).  
The most damaging co-infectious relationship for PLHIV is that with Mycobacterium 
tuberculosis (TB). Globally, about one-third of all PLHIV are co-infected with TB due to their 
compromised immune systems and a resulting 20- to 37-fold increased chance of becoming 
infected with the bacteria. HIV and TB both exacerbate the effects of the other pathologically, 
yet tracking co-infection accurately is difficult because the presence of HIV obstructs the 
diagnosis of active TB (Getahun, Gunneberg, Granich, & Nunn, 2010). Approximately 26% of 
HIV/AIDS deaths worldwide are attributed to TB co-infection, representing the largest single 
cause. Of these deaths, 99% occur in resource-limited developing countries (Pawlowski, Jansson, 
Sköld, Rottenberg, & Källenius, 2012). 
Epidemiology of HIV/AIDS in India 
Despite having a low HIV prevalence of 0.26% (ages 15-49), a population of over 1.27 
billion people places India third highest (and highest in Asia) in the ranking of countries of 
absolute number of HIV cases, currently estimated at 2.2 million PLHIV (Central Intelligence 
Agency [CIA], 2016; National AIDS Control Organization [NACO], 2015a). The national 
prevalence trend has been steadily decreasing since an estimated peak of 0.38% between 2001 
and 2003. In 2015, there were approximately 86,000 new HIV infections. Children less than 15 
years of age account for 6.54% of all PLHIV in India, and comprised about 12% of new 
infections in 2015 (NACO,2015a). Geographically, the state with the highest prevalence is 
4 
 
Nagaland (.88%), in the extreme northeast part of the country. Most of the states with a higher 
prevalence than the national level, however, are located in central and southern areas such as 
Andhra Pradesh (0.59%), Karnataka (0.53%), and Maharashtra (0.40%) (NACO, 2015b).  
Within India, women comprise 40.5% of all PLHIV (NACO, 2015a), a proportion that 
has been increasing despite declines in the number of infections among female commercial sex 
workers (Schensul et al., 2006). This trend suggests that more women are being infected by 
males through sexual contact occurring within an “intimate partner” or heterosexual marriage 
relationship. Transmission of HIV within the context of a marriage relationship is now 
considered the primary HIV infection pathway for Indian women (UNAIDS, 2009a). Over 90% 
of HIV-positive females living in India indicate that they are married and practice monogamy, 
placing the likely source of HIV in men’s extramarital sexual contact with an infected sex 
worker (UNAIDS, 2009a; Silverman, Decker, Saggurti, Balaiah & Raj, 2008). This same 
infection pathway mirrors a major source of HIV transmission married women elsewhere in the 
world, particularly in Sub-Saharan Africa and Southeast Asia (UNAIDS, 2009b; Ramjee & 
Daniels, 2013).  
One significant exception to the heterosexual pathway of the virus in India is the presence 
of intravenous drug use (IDU) as the major risk factor in some Northeastern states. As of 2010-
2011, the national HIV prevalence of IDU was 7.14% (Fettig et al., 2014; NACO, 2015b). Other 
high risk groups tracked by NACO and targeted for interventions include MSM (4.43% 
prevalence), Hijras and other transgender individuals (8.82%), long distance truckers (2.59%), 
and migrants (0.99%) (NACO, 2015b).  
Antiretroviral Therapy: HIV as a Chronic Disease 
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Antiretroviral Therapy (ART) is a combination of drugs taken orally that suppresses the 
replication of HIV and it must be taken for the full extent of a patient’s life. Early initiation and 
proper adherence to ART regimens greatly increases the overall health and survival those 
infected, and reduces the probability of further HIV transmission through a decrease in viral load 
(Deeks, Lewin, & Havlir, 2013). The increasing availability of ART globally has led to rapid 
declines in global mortality associated with HIV/AIDS, as well as declines in global incidence 
given the reduced chance of passing on the virus through sexual contact. ART has been shown to 
mitigate the susceptibility to opportunistic infections such as TB (World Health Organization, 
2013a) and life-expectancy among PLHIV, even in high prevalence areas, is nearing that of the 
normal population. With decreasing mortality and greater life expectancy, the number of PLHIV 
(HIV prevalence) grows each year despite lower incidence rates. This increase in patients leads 
to an increasing burden for the Indian health care system as PLHIV must deal with  aging, drug 
toxicity, and co-morbid conditions like cancer and cardiovascular disease (Deeks, Lewin, & 
Havlir, 2013; Fettig et al., 2014; Reynolds, 2011). 
The clinical and public health successes of ART have led to the argument that the 
epidemiological profile of HIV now is more characteristic of a chronic disease (Deeks, Lewin, & 
Havlir, 2013; Maartens et al., 2014; World Health Organization, 2006a). Scandlyn (2000) and 
other anthropologists have noted that HIV as a “manageable” chronic disease is largely a 
Western construct and only possible in wealthy nations with relatively easy and consistent access 
to care and ART medications (Scandlyn, 2000). The large economic and social costs that 
individuals face in trying to access regular care in  resource-poor, low-and-middle income 
countries (LMICs) does not allow them to live up to the “promise” of a normal life inherent to 
the Western idea of chronic diseases (McGrath et al., 2014). Some of the socioeconomic barriers 
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may be mitigated, however, with the availability of free or low-cost medications and public 
healthcare services. 
ART Coverage and Delivery 
  As of yearend 2013, about 11.7 million people in LMICs globally were receiving ART, 
representing approximately 36% of PLHIV living in those areas. In high income countries 
(HICs), approximately 1.2 million, or 52% of PLHIV were accessing ART with consistent ART 
supply, advanced diagnostic capabilities, and general access to healthcare services (Sullivan, 
Jones, & Baral, 2014; World Health Organization, 2014). Despite great progress in global ART 
coverage, 64% of those infected in LMICs are not linked to care as a result of inadequate 
healthcare delivery systems. The continued spread of the virus among highly-stigmatized 
subgroups such as MSM, transgender or IDUs, the low coverage (24%) of ART in positive 
children, and lack of healthcare access in large special populations such as migrants and 
prisoners account for much of this gap in linkage to care (UNAIDS, 2014b).  
 ART delivery in HICs is characterized by a highly individualized approach involving 
specialized physicians located in centralized treatment facilities, early initiation of multiple ART 
regimens that are tailored to the clinical situation, the frequent monitoring of patient progress and 
viral load results, and the adaptation of drug regimens (switching to “Second line” ART) based 
on regular drug-resistance testing (Gilks et al., 2006; Maartens et al., 2014; Munderi, 2010).  
In contrast, the delivery of care in LMICs has required an alternative, “public health 
approach” in order to get as many PLHIV treated as possible. This approach, introduced by the 
WHO in 2006, involves standardizing several aspects of HIV care: ART initiation (originally set 
at CD4 counts of 350), dosage of first line medications, limited clinical evaluation and CD4 
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monitoring, and population-based resistance management (WHO, 2006a). Care is recommended 
to take place in decentralized facilities at the level of health districts by utilizing fewer 
physicians and more nurses and community health workers (Gilks et al., 2006; Maartens et al., 
2014).  
Evaluations of this public health approach to HIV treatment in LMICs have been 
variable, with great benefits inherent to connecting more PLHIV with care, yet with a wide range 
of early mortality numbers reported. This range may be due to later initiation of ART during 
more advanced stages of HIV and the presence of deadly TB co-infections in extremely poor 
areas (Bartlett & Shao, 2009; Gupta et al., 2011). The WHO has since addressed the former 
mortality issue by altering clinical recommendations to begin ART treatment earlier, when CD4 
counts are less than 500 (World Health Organization, 2013b).  
Factors Impacting ART Adherence  
 Poor ART adherence directly influences the clinical progression of HIV by increasing 
viral load, decreasing CD4 counts, increasing vulnerability to opportunistic infections, and 
encouraging the development of viral mutations and drug resistance. These negative effects are 
connected with the progression to AIDS and mortality (Kagee et al., 2011; Mannheimer et al., 
2005). Maintaining at least 90-95% adherence to a prescribed ART regimen is essential to the 
success of the treatment for both PLHIVs’ quality of life, and to the public health benefits of 
transmission reduction and resistance control (DiIorio et al., 2009).  
Several studies mentioned the need for 95% ART adherence in order to maintain viral 
suppression, but this benchmark has been difficult to achieve for many PLHIV in diverse high-
income and low-income countries globally (Joglekar et al., 2011; Nachega et al., 2015). The 
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factors underlying ART adherence are extremely diverse and context-specific, ranging from 
macro-level structural and systemic barriers, to meso-level issues with communities and social 
support, and micro-level personal behaviors, coping mechanisms, and mental health. 
Systemic and Environmental Factors 
 Inadequate funding of  the healthcare system, delays in drug manufacturing, sociocultural 
barriers such as gender inequities, transportation limits, poor health literacy, food insecurity, and 
variable work schedules all may limit the ability of the health care system to maintain a constant 
supply of medication (Kagee & Delport, 2010; Kagee et al., 2011). In the context of India, the 
cost and time required to travel to ART centers has been cited by PLHIV as a major access 
barrier in Mumbai, despite the free availability of public ART medication (Joglekar et al., 2011). 
The issue of travel cost in Mumbai also relates to insufficient health infrastructure if the current 
number and distribution of ART centers is not fully meeting the needs of patients and must refer 
out to hospitals or other specialized care locations.  
An example of a systemic issue from India occurred in 2014 when governmental budget 
cuts to HIV and TB control programs led to sporadic shortages of ART medications and CD4 
testing kits. During this time some ART centers were only able to dispense medications for 7-10 
days at a time instead of the normal 30-day set of doses (Sharma, 2015), requiring PLHIV to 
make multiple trips for medication per month rather than one. 
Community & Social Support Factors  
 Social support, particularly support from families and spouses, is the most commonly 
discussed factor related to ART adherence across qualitative studies completed in 32 different 
contexts internationally, including India (Katz et al., 2013). Another meta-analysis that included 
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50 qualitative studies focused on a variety of chronic disease contexts, including HIV, found that 
practical social support (including transportation and picking up drugs) from family or friends, 
was consistently associated with greater medication adherence (Scheurer, Choudhry, Swanton, 
Matlin, & Shrank, 2012).  
Alternately, it has been found that negative relationships at the family level contribute to 
gaps in ART use when PLHIV feel that they must conceal their medication or isolate themselves 
from family when physical symptoms of HIV present (Katz et al., 2013). There is also evidence 
from Sub-Saharan Africa that social support networks and adaptive coping strategies (acceptance 
of diagnosis, willingness to seek mental health care) together can mitigate the negative effects of 
systemic barriers and poverty on ART adherence (Ware et al., 2009). In Thailand, living in a 
supportive social environment in which one feels accepted as a PLHIV at the community level 
was found to be associated with improved mental health (Ichikawa & Natpratan, 2006).   
In the Indian context, a qualitative study based in Chennai found that social support with 
ART medication reminders was a major facilitator of overall adherence, with non-spousal family 
members providing the most assistance, followed by spouses, and the least support provided by 
friends (Kumarasamy et al., 2005). Another study based at private ART clinics in Mumbai found 
that social support from family and friends in the form of ART dose reminders and fostering self-
efficacy, was associated with an optimal (95%) level of adherence (Shah et al., 2007).  
Mental Health Status 
Major depression, anxiety, mania, suicidality, and alcohol/substance abuse are all 
common mental health issues among PLHIV globally (Badiee et al., 2012; Chandra, Ravi, Desai, 
& Subbakrishna, 1998; Cruess et al., 2003; Nakimuli-Mpungu et al., 2012; Nel & Kagee, 2011; 
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Rabkin, 2008). Depression is the most frequently cited mental health issue related to non-
adherence because its clinical symptoms, particularly lack of motivation, lack of concentration, 
and feelings of worthlessness, all have direct impacts on the desire to follow a daily medication 
regimen (Nel & Kagee, 2011). Several studies were conducted regarding depression among HIV 
patients in India. One study assessed the prevalence of mood disorders among heterosexual 
PLHIV in Bangalore. Anxiety disorder was found in 36% of the sample, 40% were diagnosed 
with depressive disorder, and 47% were abusing alcohol (Chandra et al., 1998). A study of 250 
PLHIV people using public ART in Delhi concluded that “sound mental health” was a vital 
facilitator for ART adherence (Anuradha et al., 2013). Another mental health concept of vital 
importance in India is a culturally-based syndrome known as tenshun. Physical and mental 
symptoms of tenshun can include sadness, worry, weakness, or even pain. The sources of 
tenshun in an individual can likewise be diverse, including personal, economic, social problems, 
or medical concerns (Maitra et al., 2015) 
Alcohol Use 
The casual linkage and co-occurrence between depression and alcohol use is well known, 
and the effects of both on public health is well established. The WHO has classified alcohol 
abuse as the third, and depression as the fourth, largest risk factors for both disease burden and 
causes of disability globally (Witkiewitz & Stauffer, 2014, p.148). In the context of HIV, alcohol 
has been implicated in making the symptoms of HIV more severe through a direct biological 
relationship with increased viral load and immunosuppression, increasing the toxicity of ART 
drugs, and hindering the behaviors necessary for proper adhering to ART regimens (Chander, 
Lau, & Moore, 2006; Hahn & Samet, 2010; Hendershot, Stoner, Pantalone, & Simoni, 2009).  
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Heavy alcohol use is common among men in India and has been associated with greater 
sexual risk behavior among PLHIV accessing female sex workers in Mumbai, a major driver of 
the HIV epidemic in India (Madhivanan et al., 2005). In a study based in South India, alcohol 
use, depression, and stigma were all cited predictor of sub-optimal ART adherence (Achappa et 
al., 2013).  
HIV-Related Stigma  
 Various forms of stigma have been broadly implicated as one of the primary barriers to 
the success of controlling and treating HIV globally (Mahajan et al., 2008; UNAIDS, 2014a). 
HIV-related stigma  is shown to have a direct impact on accuracy in public health surveillance 
(Giesceke, 2002), to hinder access to testing and prevention services (Kalichman & Simbayi, 
2003), to be a barrier to accessing and adhering to HIV treatment (Katz et al., 2013; Sayles, 
Wong, Kinsler, Martins, & Cunningham, 2009), to disclosing one’s HIV status (French, Greeff, 
Watson  J., & Doak  M., 2015), to maintaining a supportive social network (Li, Lee, 
Thammawijaya, Jiraphongsa, & Jane, 2009), and to damaging the mental health status of PLHIV 
(Simbayi et al., 2007), across different global settings. HIV stigma may come from any level of a 
societal system, from systemic, institutional, community-based, social, inter- or intra-personal. 
Since stigma has been implicated in so many realms, there is significant diversity in its 
classifications, causes, expression, and effects, all highly dependent on cultural contexts 
(Mahajan et al., 2008). 
Defining & Categorizing HIV Stigma 
 Since Goffman (1963) first conceptualized the modern idea of stigma, many definitions 
and applications have been introduced using different theoretical approaches, including a socio-
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cognitive approach from psychology, a structural approach from sociology, and an embedded-
moral approach from anthropology (Kleinman & Hall-Clifford, 2009; Mahajan et al., 2008). 
According to UNAIDS (2000, p.9), stigma is broadly defined as “a powerful means of social 
control applied by marginalizing, excluding and exercising power over individuals who display 
certain traits.” A recent conceptualization of stigma has been presented as a combination of the 
socio-cognitive and structural approaches, making it useful for public health research (Link & 
Phelan, 2006). In this generalized model of stigma, people (1) identify and label differences, (2) 
a labeled person in connected with “undesirable” characteristics and stereotypes, (3) the labeler 
group separates themselves from the labeled, (4) the “undesirable” group loses status and faces 
discrimination, and (5) the labelers exercise power (Link & Phelan, 2001). HIV-related stigma is 
defined as:  
“…negative beliefs, feelings, and attitudes towards people living with HIV, groups 
associated with people living with HIV (e.g., the families of people living HIV) and other 
key populations at higher risk of HIV infection, such as people who inject drugs, sex 
workers, men who have sex with men and transgender people.” (UNAIDS, 2014a, p. 2) 
 
From these generalized definitions and characterizations of stigma, researchers and 
interventionists have developed useful sub-categories that outline the nuances of HIV stigma. 
Some of the most relevant types and a selection of their varied definitions are below.  
Internal Stigma (sometimes called Internalized, Felt or Self-stigma) has been 
characterized in several ways. Steward et al. (2008, p.1126) defined it as the “extent to which an 
individual accepts stigma as valid” and Bharat (2011, p.143) defined it as “stigma whereby 
those infected tend to accept stigmatization from others, feel guilty and justify the discriminatory 
behavior of others towards them.” A psychiatric definition labeled internal stigma as the “shame 
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and expectation of discrimination that prevents people from talking about their experiences and 
stops them seeking help” (Gray, 2002, p.72).  
Perceived Stigma (also called Felt-Normative) generally refers to “the subjective 
awareness of stigma, a belief about the prevalence of stigmatizing attitudes among people in the 
local community, or the degree to which stigma is perceived as normative” (Steward et al., 2008, 
p.1126). Related to this perception of stigma in the community is Vicarious Stigma, which 
“helps to explain how stories about enacted stigma and its consequences are communicated and 
form the basis for felt normative stigma” (Bharat, 2011, p. 145).  
Enacted Stigma (also called External Stigma or Discrimination) is “unfair and unjust 
treatment of an individual based on his or her real or perceived HIV status” (UNAIDS, 2014a). 
Enacted/External stigma can occur in the context of families, social situations, and healthcare 
settings through excommunication, lost housing, lost employment, or denial of necessary 
services.  
HIV Stigma in India 
Early research on HIV stigma in India had focused on surveying the thoughts of non-
PLHIV, finding that discriminatory, devaluing, and fear-based beliefs about HIV patients were 
widespread and embedded in a variety of settings and populations including a general adult 
sample, health care workers, pregnant women, and college students. Multiple studies indicated 
that between one-third and 50% of these groups pointed blame at the PLHIV, avoided them in 
everyday life, and supported their isolation in healthcare facilities (Bharat, Aggleton, & Tyrer, 
2001; Bharat, 2011). Much of the research in India has since shifted to the perspective of 
PLHIV, as victims of stigma.  
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Through an extensive meta-analysis and review of existing stigma research in India, 
Bharat (2011) identified several common situations and settings where different forms of stigma 
took place. Fear of HIV status disclosure were most commonly reported, and involuntary 
disclosure occurring in a healthcare setting or by a healthcare worker was often the start of the 
PLHIV’s experience with stigma (Bharat, 2011, p.142). A key facet of disclosure fear is that 
concern over who may learn about one’s status and what the consequences may be is often not 
based on actual experience with enacted stigma or discrimination. In India and other Southeast 
Asian countries, reports of enacted stigma were relatively low, but fears of perceived or felt-
normative stigma were high (Bharat, 2011, p.143).  Healthcare settings are found to be the 
primary location of enacted stigma, discrimination, and patient avoidance in India (Bharat, 2011, 
p. 144). Fears of status disclosure, enacted stigma, and perceived stigma were also found as 
barriers to adherence in a Mumbai-based study (Joglekar et al., 2011).  
For male PLHIV in India especially, blame and shame are important aspects of perceived 
and felt-normative stigma’s effect. In 2001, Bharat found that infected men were viewed as 
having a “loose moral character” because of the well-known connection between HIV 
transmission and visiting commercial sex workers (Bharat et al., 2001). The acceptance of this 
sort of blame and sha1me, as well as any justification for discrimination against themselves or 
other PLHIV, is a hallmark of internalized stigma (Bharat, 2011). This “self-endorsement” of 
stigma was more explicitly modeled in a study based in southern India that demonstrated a close 
interaction between avoiding status disclosure, depression, and internal stigma (Steward et al., 
2008). The modeling performed in this study included enacted stigma, and two forms of 
perceived stigma: felt-normative and vicarious. The interaction between the two perceived forms 
of stigma were connected to depression and psychological distress only through the mediating 
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variable of disclosure avoidance, while internal stigma demonstrated a robust and direct 
connection to depression (Steward et al., 2008). Beyond India, studies based in Sub Saharan 
Africa have demonstrated a close association between internal stigma and depression (Okello et 
al., 2015; Shittu et al., 2014; Simbayi et al., 2007).  
Thesis Objectives 
 The first objective of this thesis is to describe internal stigma among HIV positive men 
who are enrolled in ART and regularly consume alcohol in urban India. The second objective 
seeks to examine the systemic, social, and behavioral correlates of internal stigma using 
quantitative and qualitative sources of secondary data. The final objective is to assess the utility 
of a range of approaches to addressing internal stigma within the Indian context to improve 
treatment and prevention programs.   
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Chapter Two - Methodology 
The RISTHA/AIM Project  
The data on which this thesis is based were collected as a part of the RISHTA / AIM 
Project, “Alcohol and ART Adherence: Assessment, Intervention and Modeling in India” (2014-
2019; U01AA021990-01; S. Schensul, J. Schensul, N. Saggurti, A. Sarna, MPIs). This project is 
a transdisciplinary, Indo-United States collaboration known as the Research and Intervention in 
Sexual Health: Theory to Action (RISHTA) program. Since 2001, RISHTA has consisted of a 
series of India-based, NIH-funded projects that have included a focus on men’s sexual health, a 
project on the role of marriage in HIV and STI transmission, and a study focused on women’s 
sexual health (Schensul, Verma, Nastasi, Saggurti, & Mekki-Berrada, 2009; International Center 
for Research on Women [ICRW], 2014). 
The formative objective of the RISTHA/AIM project was an assessment of ART services 
in selected urban centers of Maharashtra, India. This was achieved in part through key informant 
interviews (KII) with staff at India’s National AIDS Control Organization (NACO), state-level 
and city-level HIV/AIDS control organizations, and at ART centers. In-depth interviews (IDI) 
with 55 male PLHIV using ART services were another aspect of this goal and are detailed in the 
next section. The analysis of these IDI form the qualitative basis of this thesis. 
 Participants for the RISTHA/AIM project were recruited across five different ART 
Centers across Mumbai, Navi Mumbai, and Thane. The eligible study population consisted of 
adult males who were 18 years of age or older, HIV-positive, had been on ART for at least six 
months, and consumed alcohol in the previous 30 days. Eligibility among ART patients is first 
determined by administration of the three-question Alcohol Use Disorders Identification Test—
Consumption (AUDIT-C) used to assess if the individual consumes any alcohol in the last 30 
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days. If the individual was an alcohol user, they are recruited for the study and given the pre-
baseline survey questionnaire used as the quantitative basis for this thesis. The RISTHA team 
was called on by NACO to conduct this pre-baseline survey measuring sociodemographic 
information, evaluation of ART services, alcohol and tobacco use, sexual behavior, the presence 
of co-morbidities, ART adherence across four-day and 30-day timespans, dietary intake, the 
individual’s social support system, psychological well-being, and their experience with stigma. 
The 361 individuals who took this pre-baseline survey were then re-recruited into the 
intervention phase of the AIM project. The analysis of these 361 surveys form the quantitative 
basis of this thesis.  
 The second objective of the RISTHA/AIM project is the implementation of individual, 
group, and community-level interventions designed to reduce alcohol consumption among male 
PLHIVs and increase ART adherence. Each of the intervention types are currently being 
introduced at separate ART centers, with second and third levels added in different combinations 
and in a staggered fashion over the course of the project.  Throughout the intervention phase of 
the project, several biopsychosocial indicators viral load, CD-4 counts will be evaluated in the 
participants including drug and alcohol use, co-morbidities, levels of social support, depression, 
and most importantly, internalized stigma.  
The intention is to measure internalized stigma using two previously developed subscales 
that focus on “Felt-normative” stigma and “Self-stigma” in India (Steward et al., 2008). It is 
important to note that the Internal Stigma scale used as a dependent variable in this thesis is 
related to, but not a direct adaptation of, the scales developed by Steward et al, and was created 
from unique questions in the pre-baseline questionnaire.  
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 The third objective of RISTHA/AIM is a synthesis and modeling of data from the first 
two phases of the project in order to assess the most impactful sequencing of the multi-level 
interventions on further HIV transmission and the quality of life experienced by PLHIVs in the 
study population. 
Qualitative Data Collection for RISTHA/AIM 
Field observations of ART Centers and key informant interviews (KII) with ART Center 
staff (including Counselors and Medical Officers) were used in the formative phase of 
RISTHA/AIM to compare and contrast the operational policies of ART Centers with actual 
“Ground Reality” practices. This research was completed at seven ART Centers as part of the 
RISTHA/AIM project’s review of ART services offered in Mumbai (Brault, 2015). The KII data 
were used in this thesis to demonstrate gaps in the delivery of ART services, particularly those 
that related to HIV stigma and counseling at the individual and group levels.  
For the collection of IDIs, a purposive sample of approximately 10 individuals from each 
of the five ART centers (N=55) involved who were deemed eligible for the study were selected 
and consented to participating in life course interviews. These IDI were asked about their 
personal experience living with HIV, specifically regarding their use and adherence to ART, the 
influence of alcohol consumption on ART adherence, the impact of HIV on their families and 
social support system, their sexual behavior, and the role HIV-related stigma plays in their lives. 
The interviews were conducted in either Hindi or Marathi by project staff who recorded 
responses on paper or an electronic recording device. These notes or recordings were then 
transcribed and translated into English before being uploaded into Atlas.Ti. (Version 7) 
qualitative analysis software. The AUDIT responses and basic demographics of the interviewee 
were also included in each IDI transcript. The demographic information included age, years of 
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education, ethno-religious category, marital status, number of children, and estimated monthly 
income.  
The IDI data were utilized in two primary capacities. In Chapter 3, themes were 
identified and quotations selected to exemplify themes that arose out of the IDI’s personal 
experiences with ART Center services and relationships with staff. In Chapter 4, IDI were 
analyzed for the primary objective of this thesis, to elucidate the quantitative relationships 
between various social and behavioral factors and internalized stigma. 
Preliminary Analysis of Qualitative Data 
 Prior to performing the qualitative analysis, the author was employed as a Research 
Assistant on the RISTHA/AIM project, tasked with managing, coding, and analyzing the 
formative IDI data. Throughout this process, the original coding guide (Appendix 1) developed 
by the Research Team was utilized. This coding guide was formatted using a Tree Diagram 
method such that multiple Factor codes were grouped into larger Domains. To illustrate this 
organization, the guide includes the Sexual Behavior domain that is subsequently divided into 
three Factors: Sexual Behavior-Wife, Sexual Behavior-Other Partners, and Sexual Behavior-
Condom Use. In another example, the Stigma domain is broken into Internal and External 
factors.  
When necessary, some edits and additions were made to the guide when new themes 
needed investigation. One instance of such a change was the addition of the Positive and 
Negative Coping codes that looked at any strategies men used to deal with the challenges of 
living with HIV. These and other new domains/factors were produced through an Atlas.Ti 
Network Sorting method that assigned the new code to relevant, pre-coded quotations. The 
20 
 
coding process required careful reading of each IDI for accuracy. For comparative analysis 
purposes, each participant was assigned to one of three major families most relevant to the AIM 
project: those that indicated full adherence to ART, those who were non-adherent to ART 
explicitly because of alcohol use, and those who were non-adherent for other reasons.  
In addition, the author produced Code Summaries, ART adherence diagrams visually 
demonstrating the behaviors and circumstances that impacted medication adherence, and coping 
strategy narratives for intervention purposes. The primary technique of qualitative analysis was 
the summarization of codes (Code Summaries), a process that is detailed later in this chapter.  
Hypotheses & Logic Model 
 Experience with coding and analyzing the IDI data, along with reviews of the literature 
on HIV stigma in India, led to the choice of the independent variables included in the final 
statistical model. I hypothesized that the following variable groups would be associated with 
feelings of internalized stigma: (1) an individual’s level of social support (from family, friends, 
NGOs, and ART Centers), (2) their mental health status (depression, tenshun, & alcohol use), (3) 
experience with external HIV stigma and discrimination, (4) experience with HIV & ART (time 
since diagnosis, time since initiation), and (5) the individual’s general quality of life (General 
health status, food security, presence of other STIs). These hypotheses are visualized in the logic 
model below (Figure 1). 
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Figure 1. Logic Model.  
 
  Although all of these factors were hypothesized to be connected to the development of 
internal stigma, it was further predicted that mental health status would demonstrate the strongest 
association. Preliminary analysis demonstrated that interactions among these factors could 
directly influence the individual’s mental health status; manifesting as HIV-related stress, 
tenshun, depression, or suicidality.  
Definition of Variables & Scale Construction 
Internal Stigma  
The Internal Stigma Scale was created by combining the response scores to 16 statements 
from the pre-baseline survey referring to men’s experiences, beliefs, and fears regarding living 
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with HIV, focusing mainly on issues of status disclosure, self-blame, and loss of social networks. 
Two examples of statements used in this scale are “I feel I am not as good a person compared to 
others” and “I worry that people may judge me if they knew my status” Responses to each of the 
16 statements were recorded on a four-point Likert scale, from “Strongly Disagree” (1) to 
“Strongly Agree” (4). Agreement with each statement on the Scale is deemed a form of negative 
perception, such that a higher combined score is indicative of greater internalized stigma. The 
Internal Stigma Scale produced a high level of internal reliability, with a Cronbach’s Alpha (α) 
score of 0.89. All 16 statements that comprise the scale and the distribution of responses are 
included in Table 2 of the Integrated Results chapter. 
Qualitatively, the description associated with the Internal Stigma code in the IDI Coding 
guide was as follows: “Self-blame, guilt, lack of self-respect or positive attitudes, any self-harm, 
aversion to socialization, any mention of phobia or the lack thereof.” The occurrence of any of 
these emotions or behaviors were coded as Internal Stigma across all 55 IDI. 
Depression & Emotional Status 
Quantitatively, depression was measured using an adapted Center for Epidemiologic 
Studies Scale for Depression (CES-D Scale; α =0.69) (Radloff, 1977). This scale was based on 
ten statements that asked the respondent how often they felt different emotions, both positive and 
negative over the course of the previous week. Each emotion can be rated as being felt “Rarely 
or none of the time (< 1 day),” “Some or a-little of the time (1-2 days),” “Occasionally or a 
moderate amount of time (3-4 days),” or “Most or all of the time (5-7 days).” Some of the 
statements included in the CES-D Scale were, “I was bothered by things that usually don’t 
bother me,” “I felt hopeful about the future,” and “I felt lonely.”  
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The External Tenshun Scale (α = .80) was another indicator of mental health status in 
which an individual’s level of tenshun related to issues such as difficulty with work, one’s 
financial situation, or disclosure of HIV status was assessed. The External Tenshun scale is a 
five-question subscale dealing with these “External” issues beyond immediate and extended 
family relationships. The remaining six questions in the main Tenshun scale relate to issues 
associated with the men’s wives, children, in-law families, and sex partners. For each statement 
in the scale, the respondent can indicate whether it contributes to their level of tenshun “To a 
great extent,” (1) “To some extent,” (2) or “Not at all” (3). A lower mean in this sub-scale 
indicated the experience of more tenshun. 
Qualitatively, several codes were used to investigate the connection between mental 
health issues and internal stigma. The Emotional Status domain dealt with “Current tension 
(tenshun), stress, depression, anxiety, or coping strategies.” Instances of fear and anxiety over 
HIV disclosure beyond one’s family or other trusted individuals was frequently coded as an issue 
of mental health using the Emotional Status code. The Diagnosis Response code was applied to 
passages describing the effect of receiving their initial HIV diagnosis, including “Immediate, 
ongoing, and evolving response to the news; beliefs, denial and acceptance, sharing, and 
trauma.” The Positive Coping and Negative Coping codes were also used to identify examples 
of mental health status in the IDI data.  Positive Coping included examples of men finding a 
community with other HIV positive people, participation in religious activities, the use of prayer, 
positive and future-based thinking, social responsibility to protect others from infection, benefits 
of status disclosure, a focus on nutrition & exercise, seeking support from others, or taking pride 
in a craft or work. Negative coping overlapped significantly with Emotional Status and Internal 
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Stigma, highlighting instances of problem drinking, suicidal thoughts, feelings of guilt or blame, 
self-isolation, and anger. 
Aside from the Alcohol Use Disorders Identification Test (AUDIT), the seven- question 
Reasons for Drinking Scale (α=.52) was used to quantitatively assess why the sampled men 
consume alcohol. For each statement, only a Yes (1) or No (2) was available, such that a lower 
mean indicated that the individual expressed more reasons to consume alcohol. “I have more 
courage,” “I have less tension,” and “I can cope better with HIV” were among the statements 
included in the scale. The statements used in the creation of this scale were developed through 
preliminary analysis of the qualitative data by MPIs for the RISTHA/AIM project. 
Several codes were utilized to assess past and present drinking behaviors among the men 
in the IDI sample. Most relevant for this study was Alcohol_Post-Diagnosis, a factor that focused 
on the effect HIV diagnosis had on the individual’s frequency, quantity, and justification for 
drinking. Further, the Alcohol Reasoning code identified responses to an interview probe 
questioning why men (in a general sense) consumed alcohol. Finally, two codes meant to 
evaluate the effect of alcohol on ART adherence were useful to investigate for this thesis. 
Adherent_Alcohol was used whenever the interviewee discussed how he was able to maintain 
adherence to his medication regimen despite the use of alcohol. The Non-Adherent_Alcohol 
code was used when the men attributed their non-adherence to ART to their own drinking 
behavior.  
Social Support  
The 11 questions that comprised the NGO (α=0.73), ART (α=0.57), and Family (α=0.91) 
Support Scales referred to receiving assistance from each of these groups in a variety of realms, 
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including ART adherence and medical treatment, meeting psychological and emotional needs, 
financial support, informational and legal support, and in participation with social networks or 
programs. The separate scales were able to be created because answers corresponding to each 
group were embedded within a series of Yes/No questions. For instance, for the category 
“Psychological/Emotional support,” respondents can answer whether or not they receive support 
in that realm from each of Family, Friends, NGOs, and/or ART centers. Since each category gets 
an answer, separate scores could be calculated.  
Social support was also measured quantitatively in the Network of Positive People 
Support (NMP+) Scale (α=.85). This scale measured the amount of support received specifically 
from the Network of Maharashtra People with HIV (NMP+) NGO across 19 different categories. 
The respondent could answer Yes (1) or No (2) to each type of service, so that higher mean on 
this scale indicated that fewer supportive services were received. Some examples of the services 
asked about in this scale include, “Counseling on positive living and acceptance of HIV positive 
status,” “Provided with information on STI/HIV/AIDS,” and “Education on importance of 
adherence and side effects of medication.” 
The presence or lack of social support in relation to internalized stigma was again defined 
and extracted using multiple codes across the IDI data. A Social Support code domain was used 
as an overall guide, with additional codes used to specify different support relationships. The 
primary Social Support code referred to any people in the respondent’s personal network who 
provided money, transportation, support of the family, assistance with medication pick-up and 
adherence, and/or emotional support. At the family level, the Wife code was utilized extensively 
to identify the presence (or absence) of social and emotional support for the interviewed men. 
This code was for any examples of non-sexual aspects of the marital relationship, including 
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issues of communication, blame for HIV, domestic violence, and support. The Household 
Dynamics and Extended Family codes were used to identify positive or negative examples of 
social support among the rest of the sample’s families. Finally, support originating from NGOs 
and ART centers could be located using the NGO Involvement code and any factors within the 
ART Centers code domain.  
External Stigma  
The 19 component questions of the External Stigma Scale (α=.80) refer to discriminatory 
situations originating from a variety of sources: spouses, family members, sex partners, 
employers, neighbors, medical personnel, banks, and other social services.  The questions were 
answered in a Yes (1)/No (2) format such that lower values are given to negative outcomes 
(more experiences with enacted stigma). Example questions from the baseline survey that were 
combined to form the External Stigma Scale include: “Have any of your own family members 
shunned or rejected you because of your HIV infection?” “Has your spouse left you permanently 
or temporarily?” and “Has any neighbor said negative things about you to others because of 
your HIV infection?” 
The External Stigma code was applied during preliminary analysis of the interviews 
when examples of negative reactions or outright rejection occurred from medical personnel, 
community members, friends, family, or co-workers. Any positive reactions from these groups 
were also highlighted using this code. Thematic overlap with other codes was also evident during 
the process of qualitative analysis for this thesis, leading to the discovery of additional examples 
of enacted stigma or fear of enacted stigma after individuals heard stories of HIV-based 
discrimination perpetrated on others. 
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To avoid repetition, only the scales that were found to significantly contribute to the 
Standard Multiple Regression model have been defined in this section. Likewise, the only 
qualitative definitions included here are those that correspond to the IDI codes that best 
characterized the significant relationships. All of the scales were created by combining the scores 
of their respective component questions through written syntax within IBM SPSS (Version 23) 
software. 
Statistical Analysis 
All statistical analysis and survey database management were performed using IBM 
SPSS (Version 23) software. This thesis examined the correlates of internal stigma across the 
entire sample eligible for inclusion in the AIM study, thus, all statistical tests were performed 
using the full sample of 361 surveys. Quantitative analysis of the survey data (n=361) began with 
univariate descriptive statistics for all of the 21 chosen variables in order to characterize the 
study population. This included frequency distributions for all of the categorical variables and 
measures of central tendency for continuous variables. Bivariate statistics were then performed 
using Pearson’s r correlations to determine interrelationships among the chosen independent 
variables and that with the dependent Internal Stigma Scale variable.  
A Standard Multiple Regression model was then created to determine if any of the 
independent variables were significantly associated with the variation of the dependent outcome 
scale. In the Standard Multiple Regression model, all of the variables were run simultaneously 
using the “Enter” method on SPSS. Following this, in order to determine the relative contribution 
of the variables that significantly contributed to the first regression model, a Stepwise Multiple 
Regression was performed using the “Backward Deletion” method. This method removes 
independent variables from the original 21-variable model in a staggered fashion until only the 
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statistically significant predictors remain. The R2 value from the Stepwise regression was 
subtracted from the R2 of the Standard regression to determine the percentage of variation that 
non-significant variables accounted for in the Internal Stigma scale.   
Multicollinearity analysis between the 21 independent variables was also performed to 
ensure the validity of each multiple regression model. This was initially completed by analyzing 
the Correlational Matrix (see Table 5) and then by calculating Tolerance scores in the regression 
model. Any variables found to significantly contribute to the regression model with internalized 
stigma as the dependent variable then entered the second portion of the study and were 
investigated qualitatively.  
Qualitative Analysis 
All qualitative analysis and IDI management were performed using Atlas.Ti (Version 7) 
software (Atlas.Ti., 2014). There were no inclusion criteria for the sample of interviews in this 
thesis, thus, all 55 IDIs were included in the qualitative analysis.  The process of extracting 
appropriate quotations from the interviews was nearly identical to that of producing Code 
Summaries for the prior qualitative work completed with the IDI data for the RISTHA/AIM 
project.  First a query was performed to gather all of the examples of a given code from any of 
the 55 interviews. This initial set of quotations was reviewed in full and the best examples of the 
theme under investigation were highlighted and grouped by theme.  To search for quotations 
regarding a specific relationship between two variables, a more focused query was performed 
that extracted quotes featuring overlapping or co-occurring code domains or factors.  
A total of 77 quotations were originally coded as examples of Internal Stigma through 
preliminary analysis. However, many additional examples of internalized guilt and self-blame 
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arose as closely-related code domains were analyzed. An identical situation with the External 
Stigma code was described in a previous section. Domains that contained the most information 
indicative of internalized stigma included Emotional Status, Diagnosis Reaction, Post-diagnosis 
Alcohol Use, and External Stigma. This overlap was due to similarities in the behaviors these 
three codes were intended to identify based on the AIM Coding Guide.  Each time a quotation 
was identified as a clear narrative example of a particular relationship, basic demographic 
information for that individual was paired with the quote, including age, marital status, and 
number of children.  
Human Subjects Protections 
All survey and interview data utilized in this thesis has been de-identified. Procedures for 
primary data collection, intervention and evaluation have been reviewed and approved by the 
Indian Council for Medical Research, the National AIDS Control Organization within the 
Ministry of Health and Family Welfare, the India Health Ministry Screening Committee, and the 
institutional review boards of UConn Health, Population Council, the Institute for Community 
Research and the International Center for Research on Women. The author of this thesis is an 
approved personnel member for the RISTHA/AIM project on IRB submissions at UConn Health.  
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Chapter Three – Structure & Function of HIV Treatment in India 
Overview of India’s Healthcare System 
The healthcare system in India represents a complex and uneven mixture of public and 
private sources for medical care at all levels. The system as a whole is deeply underfunded to 
meet the health challenges of over one billion people, accounting for only about 4% of India’s 
Gross Domestic Product (World Bank, 2016). It is “uneven” because about 80% of outpatient 
services, and 60% of inpatient-care, comes from private providers located primarily in urban, 
single-doctor practices or in a private clinic setting (Reddy, 2015). With the majority of health 
care focused on urban areas, nearly 70% of the total population of India living in rural areas have 
poor access to the already-strained system (CIA, 2016). About 70% of the costs in the 
unregulated, profit-based system is directly out-of-pocket for patients and operates on a purely 
fee-for-service basis, further limiting healthcare access among poor people in urban areas.  The 
fee-based system may negatively impact overall healthcare quality since competition between 
doctors for patients who can afford treatment is the norm (Prinja, Kaur, & Kumar, 2012). The 
tiny fraction of publicly funded facilities that do exist provide free or low-cost care, but are 
underutilized in many states due to a prevailing belief that lack of cost translates to lack of 
quality. Although the population using public facilities is higher in rural areas, the majority of 
people still prefer private sources or rely on non-allopathic medicine. (Government of India, 
2013; International Institute for Population Sciences, 2006). 
The disciplines of non-allopathic medicine, including the traditional practices of 
Ayurveda, unani, siddha, homeopathy, naturopathy, and yoga are embedded into the cultural 
understandings of health, disease, and medical practice in India. Some 70 – 80% of the Indian 
population utilizes or relies on some form of non-allopathic medicine, particularly in rural areas 
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for the treatment of all forms of chronic, infectious, and mental health disorders (Gogtay, Bhatt, 
Dalvi, & Kshirsagar, 2002). There are extensive non-allopathic education programs located in 
medical colleges where graduates can be officially registered as practitioners by the Indian 
government through the Ministry of Health and Family Welfare (Schensul, Mekki-Berrada, 
Nastasi, Saggurti, & Verma, 2006). In major urban centers like Mumbai, more men utilize 
private practitioners of non-allopathic medicine, widely known as daktars, than the public 
healthcare system. This ubiquitous use of traditional Indian medicine puts its practitioners in a 
unique and powerful position as avenues for public health interventions (Schensul, Mekki-
Berrada, Nastasi, Saggurti, & Verma, 2006). 
Substantial changes to the healthcare system at the national level have been proposed in 
the most recent Five Year Plan (2012-2017) released by the Indian government (Government of 
India, 2013). The intention was to significantly increase central government funding toward a 
plan for universal health care, with the ambitious goal of providing free medication, diagnostic 
services, and insurance for all citizens by 2019. This core restructuring of the system, however, 
faces extraordinary challenges in political will, funding, and implementation moving forward 
(Reddy, 2015; Kalra, 2014; Kalra, 2015). 
National AIDS Control Organization & Public Antiretroviral Therapy  
Since its establishment in 1992, the National AIDS Control Organization (NACO) has 
been a subsidiary division of the Ministry of Health and Family Welfare, the Indian 
government’s highest authority on matters of public health and health policy. NACO directs a 
network of 35 HIV control and prevention societies that are distributed across India’s 36 states 
and union territories (NACO, 2016a). The programmatic functions of NACO are divided into 
two primary aims: Prevention activities and Care, Support, and Treatment for existing PLHIV. 
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Prevention activities undertaken by NACO include targeted interventions for groups at higher 
risk of HIV transmission (such as migrant workers, intravenous drug users, and female sex 
workers), condom promotion, STI/RTI control, and educational mass media campaigns. Direct 
patient care activities directed by NACO include laboratory CD4/viral load testing, distribution 
of pediatric and adult ART, and the administration of Care and Support Centers (CSC) that aim 
to improve quality of life among PLHIV (NACO, 2015b).  
NACO Care and Support Centers 
There are 325 currently-operating CSCs (44 in the state of Maharashtra) that provide 
medication adherence education, linkage to external support or social welfare services, and 
counseling on common psychosocial issues for PLHIV and their families, including internal and 
external forms of stigma (Maharashtra State AIDS Control Society[MSACS], 2015; 
NACO,2015b).  According to the most recent (2013) Operational Guidelines for CSC’s, stigma 
should be addressed at the client and family level through contact with Peer Counselors who 
“Motivate the PLHIV to address the issue of self-stigma,” and educate individuals on how to 
“overcome self-perceived stigma” (NACO, 2013, p. 24, 36). No examples or further instructions 
are given as to how stigma counseling should take place with PLHIV or their families.  
At the community level, counselors are tasked with documenting any cases of HIV-
related stigma or discrimination that they hear about, and including them in an area report for use 
in advocacy. Stigma reports from the field shape the audience and message of advocacy 
campaigns that may use mass media, petitions, or public rallies (NACO, 2013). Discrimination 
Response Teams can also be operated through CSCs, directly investigating individual acts of 
discrimination, providing moral support to victims, and seeking justice through legal means 
(NACO, 2013). Stigma is further addressed in an outreach branch of NACO programming called 
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Information, Education, and Communication (IEC). IEC utilizes scripted “Folk Media” 
performances that tailor messages of safe sex, women’s issues, and anti-discrimination in 
culturally-specific ways (NACO, 2015b). These individual and community-level programs 
addressing HIV stigma are in fulfillment of NACO’s vision statement: “Effective prevention, 
care and support for HIV/AIDS is possible in an environment where human rights are respected 
and where those infected or affected by HIV/AIDS live a life without stigma and discrimination,” 
(NACO, 2016b).  
Rollout of Public ART Services  
Amidst a WHO-led effort to expand HIV treatment in low-and-middle-income countries 
(LMIC), NACO has been providing free, publically-funded ART medication since 2004 (NACO, 
2015b; WHO, 2006b). The rollout of free ART began with the opening of eight ART Centers 
within Government hospitals located in areas with the highest HIV prevalence. The program 
expanded rapidly across India in the 10 years after the rollout, with 453 ART Centers operating 
as of 2014 (NACO, 2015b). The state of Maharashtra has 72 ART centers, 24 of which are 
located in the city of Mumbai (MSACS, 2015).  
Several types of ART Centers serve specialized roles in the ART distribution system. The 
870 Link-ART Centers each serve a smaller number of patients and offer no additional services 
but are located in more convenient locations for improved access to medication. Thirty-seven 
ART-Plus centers provide the same services as standard centers, with the addition of Second-line 
ART medication. Ten ART Centers-of-Excellence exist within major hospitals and can provide 
specialized care, Alternative First-Line and Second-Line ART, training, and research (NACO, 
2015b). 
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The total number of PLHIV in India using public ART was approximately 851,000 
between 2014 and 2015, representing 38% of the 2.2 million total nationwide (NACO, 2015a; 
2015c).  This figure is slightly higher than the estimated ART coverage across the entire 
Asia/Pacific region (33%), but lower than the Southeast Asian LMIC with the second highest 
HIV burden, Thailand (57%) (UNAIDS,2014). 
Initiating Patients on ART 
The description of the testing and ART-enrollment process that follows in this section 
was derived from NACO’s most recent Operational Guidelines for ART Centers (NACO, 2012). 
Integrated Counseling and Testing Centers (ICTC) are the first contact most individuals have 
with the public HIV-care system in India. ICTCs conduct free HIV testing and offer basic 
counseling and health education services for high-risk populations who may access testing by 
choice or be referred from a medical provider or NGO. Only individuals who test positive for 
HIV at an ICTC can be referred to an ART center for enrollment in care. Therefore, even 
individuals who may have tested positive in a private clinic setting need a confirmatory test from 
an ICTC before entering the public system. The patient’s first visit to an ART center involves the 
issuing of the “White Card” and “Green Book” for the tracking of future HIV care and a baseline 
medical assessment that screens for existing opportunistic co-infections (such as TB and STIs), 
assigns a WHO clinical stage of HIV, and conducts CD4 testing. The results of these initial tests 
are available for the patient’s second visit to the Center, in which it is determined if they are 
eligible for ART. Generally, ART will begin if the patient’s CD4 count is less than 350, or if 
other opportunistic infections are present. 
After meeting NACO’s eligibility criteria, initiation on ART should begin with a 14-day 
supply of ART drugs, counseling on ART adherence, and the identification of family or 
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community support (through a Care & Support Center). Patients return to an ART center 
counselor after the first two weeks in order to assess issues with adherence, medication side-
effects, receive psychological support, and recommendation of spousal HIV testing. A clinical 
examination and any follow-up on previously identified infections is also given.  
Process of Monthly ART Center Visits  
Subsequent visits to the ART center occur approximately once-per-month for medication 
pick-up by the patient or a family member. Prior to receiving medication from the Center 
pharmacist, an ideal sequence for each monthly visit would first bring patients to a counselor for 
adherence assessment (pill counting), advice on addressing adherence barriers, positive living 
techniques, and transmission prevention. If needed, “management of co-morbid psychiatric 
illness should be carried out” (NACO, 2012, P.37), along with linkage to group support meetings 
(held at some large ART Centers) and community-based rehabilitation centers. No further 
information is given about how psychiatric illness is managed in the Operational Guidelines. Of, 
note ART Center counselors can either have Masters-level training in social work, sociology, or 
be trained in nursing with the addition of NACO counselor training. When possible, preference is 
given to qualified PLHIV for the counselor role. 
Following the visit with a counselor, the patient then is assessed by a nurse who checks 
for HIV-related symptoms, weight loss, and screens for TB. Unless required sooner due to 
clinical need, regular CD4 counts are ordered by nurses approximately every six months. The 
final assessment before ART dispensary is with a Medical Officer who should give an exam, 
review notes from the counselor and nurse, and look for further problems with medication 
adherence and effectiveness. Of note, all ART Center Medical Officers must have an MBBS 
degree (the equivalence of a Medical Doctor) with additional training in HIV care from NACO.  
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Addressing Patient Loss to Follow-Up on ART 
 People who enter the public HIV care system through testing at an ICTC can be lost to 
follow-up (LFU) at any step of care prior to, during, and well after ART initiation. The 2012 
ART Center Operational Guidelines assigned stages to the four points in which LFU occurs. 
Most relevant here is Stage 4, accounting for any loss of patients that occurs after they have 
started an ART regimen. Internal efforts to address Stage 4 LFUs begin with a “Daily Due List” 
of people who should be arriving on any given day for their next month’s supply of medication. 
This list is maintained by the pharmacist on staff, and those who do not arrive within 48 hours 
should be contacted by telephone. If individuals cannot be contacted, outreach workers from 
ART centers, CSCs, or NGOs may be used to locate the patient. People who retrieve their 
medications irregularly (not within the month of their original appointment) are considered 
“MIS” patients. If a patient maintains MIS status after 4 consecutive months, they are considered 
“LFU.” Lists of MIS and LFU patients should be maintained and tracked by all ART centers 
(NACO, 2012). 
ART Center Services – “Ground Realities”  
 All of the information regarding NACO/ART Center policies and procedures in the 
previous section refers to the operation of their facilities under ideal conditions of center 
location, staffing, funding, medical supplies, and medication availability. At any given time, 
there may be inadequacies in one or more of these areas that lead to gaps between what is 
suggested in the ART center guidelines, and the so-called “ground realties” of actual services 
offered to PLHIV and their families. In this section, two forms of analyses are presented that 
investigated these gaps; in the first, field observations of ART Centers and key informant 
interviews (KII) with Center staff (including Counselors and Medical Officers) were used to 
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directly compare personal experiences with the content of the 2012 Operational Guidelines for 
ART Centers. This existing research was completed at seven ART Centers as part of the 
RISTHA/AIM project’s review of ART services offered in Mumbai (Brault, 2015).  
Discrepancies between NACO Policies & Practice in ART Centers 
 The KII analysis showed discrepancies across most aspects of ART Center infrastructure, 
staffing, and programing compared to the NACO guidelines that could have a negative impact on 
the quality and consistency of patient care.  The greatest concern in terms of infrastructure was 
that the size of the facilities themselves did not meet the volume of patients utilizing them, 
leading to insufficient and unpleasant waiting spaces and lack of privacy for conversations with 
medical officers and counselors. In terms of ART Center staffing, it was found that every Center 
included in the analysis was understaffed compared to guidelines, and that existing staff 
complained of inadequate training and high turnover. This lack of appropriate staff in 
overcrowded ART Centers leads to long waiting times, and the high rates of staff turnover likely 
results in further training gaps.  
 Many discrepancies were found within the areas of treatment procedures and counseling 
services that stem from the infrastructural issues above, all directly impacting the quality of care 
and support provided by the sampled ART Centers. For instance, time spent with medical 
officers seems to be limited in many cases, with physical exams being skipped and inadequate 
passage of updated patient histories occurring. Counseling at the individual level is hindered by 
low staffing, causing many sessions to be cut short without covering all of the recommended 
topics. Alcohol use is not explicitly addressed in the recommended topics, and only an 
encouragement to quit drinking is included if abuse is suspected. Finally, frequent turnover 
causes a lack of counselor continuity, making long-term relationships with patients difficult to 
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develop. Space, staffing, and training were also barriers to the running of group counselling 
sessions at most locations.  
 Issues of stigma are not directly addressed in the ART Center Guidelines. The KIIs 
indicate that outside referrals for treatment of other conditions may not be followed through due, 
in part, to fears of enacted stigma or discrimination. Similarly, disclosure-related stigma fear was 
believed to be a reason why patients may not want to access group sessions. While the interviews 
indicated a view that the impact of stigma is improving through educational campaigns and street 
performances, it remains an issue at the community and family level. 
Patient Perceptions of ART Center Services  
From the In-depth Interviews, PLHIVs commented on their ART Center experiences. 
Most participants reported that they had an overall positive experience with the services and staff 
provided at the ART centers and seven reported a negative experience overall.   
General Positive View 
“When I came here, it was very nice experience. First of all, [this center] is at the 
entrance. So it is very easy to locate it. No need to ask anybody where it is. In this center, 
everybody was there to serve me. All the staff members are very good… Each of them 
knows me personally.” 
 All staff in [this ART Center] are very good. They are giving such an expensive medicine 
in free of cost so we are grateful.”  
General Negative View 
 “Some of the patients go to [another ART Center] and get it done there. But why such 
basic test was not being done at this center. Patient get irritated as such facility is not 
provided by the center. They have to run here and there for CD4. Service provided at this 
center is of poor quality as compared to that [the other] ART center.” 
 “They are not good. They do not do their work fast. Every time we have to stand in the 
queue for long time. I get irritated to wait in the queue. Every time we have to spend 2- 3 
hours in the ART center… Sometimes I think I should stop the medicine because of 
irritability.” 
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Ten respondents indicated that they have transferred between different ART centers 
throughout the course of their treatment. The reasons for this vary. Some were changed at the 
recommendation of their private or local doctor, others were seeking a higher quality facility, or 
were forced to move to another center due to travel time or because of work.  
“I found that the [first] hospital was dirty and patients from my area is also coming to 
the first hospital for HIV treatment. Then I came to the [second hospital], it was looking 
better, clean and spacious. I said to the [third] hospital doctors to shift me and my wife to 
the [second] hospital.” 
 “I was taking ART treatment from [this ART center] for 18 months. Travelling here was 
costing a lot, so upon the doctor’s suggestion, I got transferred to this center which is 
near to my house. For that they gave me the transfer certificate and changed my address 
of ART center to [another] Hospital. Since last 1 and half year I have been seeking 
treatment from this center.” 
 
The most frequently mentioned complaint was the length of time patients were required 
to wait in the ART center to see a doctor and/or counselor, or to simply receive their 
medications. Several men did not like how impersonal the staff was at the larger hospitals, with a 
few also noting that new patients receive a disproportionate amount of attention while recurring 
patients see little ongoing support. Medicine shortages were explicitly recalled by five 
respondents, and three recalled ART center closures due to a strike.  
 “These people (ART personal) doing their job, because as a part of their duty. Otherwise 
they do not have concern about HIV patient and their illness.” 
 “Before 3- 4 years there was a strike. So I was not received medicine for two months, no 
patients received medicine during that.” 
 “Last there was shortage of medicine in this center. I came to collect the medicine but 
when I came here, and then counselor told me about the shortage of medicine…. I missed 
my more than 8 days of medicine.” 
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Many of the respondents discussed the quality of the staff at the ART centers. There were 
several mentions of how staff “shouted” at people waiting in line or who were not timely to 
appointments or with medication adherence.  The quote below discusses staff quality, both good 
and bad, across four different ART centers. 
“When I was taking the treatment from [Center #1], those staffs were good and co-
operative. They talked with me nicely and always asked about health. [Center #2] was 
the best, because their staffs were so nice and they are so enthusiastic.  [Center #2] staffs 
were also cooperative and having good nature, sometimes I reached there late but they 
didn’t shout at me. But here in new [Center #3], I don’t like to come, these staffs don’t 
have any manners about talking. They shout on the patients.” 
 
Only four men said that they do use (or would use) the ART center for anything other 
than medications. Some may not want to be seen going there on more occasions than necessary, 
others may not return simply due to the waiting time. One respondent returns for non-HIV 
related issues because of the free medication. 
 “If I catch fever and cold then also I come here and inform the doctor to get medicines. 
These medicines are free of cost. So why should I go to some private doctor for any 
health problem?” 
Interviewees were asked about the content of any medical advice given by the ART 
center physicians. The topics covered were generally diet, medication adherence, sexual health, 
and alcohol use. There were surprisingly few assessments of the quality of this medical care 
specifically, positive or negative. Most reviews focused on the staff as a whole. Two of the 4 
positive assessments both talk about a female doctor at one of the ART Centers. 
 “She properly guided me. She told me in detailed what this illness is and how with the 
help of medicines I can live the fullest of my life. She assured me that if I take my 
medicines on time, nothing would make my life shorter.” 
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 “The doctor…. I don’t remember her name…. told me not to worry. She gave me mental 
support and encouraged me to come here regularly. She said that if I take the medicines 
on time, then I can live longer life.” 
 
A couple of respondents mentioned that they received little or no advice from the doctors 
themselves, but were just referred to the counselors. Several more men said that advice about 
diet, medication adherence, and alcohol use were given only at their first visit.  
 “The doctor has prescribed some medicines to me, and explained me to take these 
medicines along with ART medicine.  Apart from this, doctor didn’t say anything.” 
“My first time, doctors and counselor here in [this Center] were asking so many 
questions about other health problems, diet, and sexual relation with wife and others. But 
now they stopped all these talking. Just they look face and write date for medicine. Even 
if I share any problem doctors/counselors are not listening now in [this Center].” 
 
Nearly all of the interviewed men discussed being seen by counselors at the ART centers. 
Common issues with counselors include a lack of personable service, not enough time spent with 
each patient, or favoring new patients over returning ones. Several respondents were upset how 
the counselors scold or shout at patients who do not follow advice.  
 “They hadn’t shouted on me, because I always come here and I don’t talk with anyone 
or with them. I come for only my medicine. I collect and go. Sometimes they shout on 
patients who are not coming regular to collect the medicine, and some of them come and 
always complained about their family. Some patients have to hurry, then they shout at the 
patients.” 
The following list represents the major topics covered by the ART Center counselors in 
order of salience, as relayed by the men in the interviews: Advice regarding ART medication 
adherence (mentioned in 16 interviews), Nutritional advice (14 interviews), information about 
sexual behavior (9 interviews), Alcohol/Tobacco control or cessation (8 interviews), and general 
HIV knowledge (7 interviews). Only two respondents said that the counselors did not mention 
42 
 
alcohol control. In relation to group meetings, at least 15 respondents said either that no group 
meetings occurred at their ART center, or that they were never informed of the existence of such 
meetings. Only eight said that they had attended or at least were aware of group meetings taking 
place. 
 “I attended three sessions in [this hospital]. They were group sessions. They talked 
about the disease, food and sex. They gave the information about the HIV and AIDS. 
They said ‘HIV is the first step of disease and AIDS is the last. If we eat nutritive food for 
good health, then we can increase our immune power. And use condom when you want to 
have sex. It is better for the other partner. And always think positive, if you take any 
tension then you will invite the other disease which is not good for your health.’” 
“I have not attended any such group meeting. Nobody tells about such things here.” 
 
Special requests for extra medication for travel reasons were generally accepted, although 
there were several men who said they are denied at every request or only occasionally receive the 
extra doses. Ease of obtaining extras was one of the many suggested improvements made by 
respondents. When these are not given, lengthy spans without ART are possible. Extra 
medication was often requested prior to traveling for work or for vising family at their native 
home. 
 “Yes, one year ago, I had gone to native place, and at that time I had requested 
counselor to provide two months’ medicine. I was not provided extra medicine, which I 
was supposed to have after going to native place.  That time I had not taken medicine for 
one and half months.” 
 
The majority of patients seem to receive their ART medication in 30-day prescriptions. 
Several men indicated that their center only gives out medication for 15-day spans, and some 
vary between 15 and 30 days due to supply issues.  
 “After the Counselor, we go and meet the doctor. The doctor asked about my problems 
and wrote medicines. Then we collected medicines from another woman. Sometimes 
medicines were given for 15 days some time they gave us for one month.” 
43 
 
Chapter Four – Results  
 This chapter will include both the qualitative and quantitative results of this thesis. First, 
demographic information from both sources will be presented in Table 1 and detailed separately. 
Following this, a description of how internal stigma was defined and characterized both 
quantitatively and qualitatively will be described. The remainder of the chapter will present 
integrated survey and in-depth interview results related to the independent variables that 
correlate with internal stigma, primarily using the qualitative data to explain the quantitative 
relationships. Inter-correlations among the contributing variables will also be discussed.  
Sample Demographics  
Table 1  
Demographics of Pre-Baseline Survey Group and In-Depth Interview (IDI) Group 
 
Characteristic Survey Group IDI Group 
Sample Size 361 55 
Mean Age (Range) 41.5 (21 - 66) 39.3 (22 – 55) 
Ethno-Religious Category   
Hindu 88.6% 74.5% 
Buddhist 7.8% 12.7% 
Muslim 1.9% 7.2% 
Christian -- 3.6% 
Jain -- 1.8% 
Currently Married 82.5% 87.2% 
Mean Number of Children 2.2 2.3  
Mean Years of Education 7.3  8.6 
Currently Employed 92.5% 89% 
Monthly Median Income (Rupees) 10000 ($150) 11500 ($173) 
HIV Positive Family Members   
Wife 42.3% 38% 
Child 15.5% 5.4% 
Other Family 1.16% -- 
Years Since HIV Diagnosis 5  -- 
Years Since ART Initiation 3.8 -- 
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Pre-Baseline Survey Demographics  
The mean age of the 361 men who completed the full pre-baseline survey for the 
RISTHA AIM project was 41.5 years, with ages ranging from 21 to 66 years. On average, this 
group has known their HIV status for 5 years and have been on an ART regimen for a mean of 
3.8 years. The majority (88.6%) of the sampled men were Hindu, yet unlike the broader religious 
composition of the region, this sample included more Buddhists (7.8%) than Muslims (1.9%). In 
terms of familial composition, 82.5% were “currently married,” Of this total, most indicated that 
they lived with their wives (71.5%) within a nuclear family structure (77%), including a sample 
mean of 2.2 children. The wives’ age averaged at 36.2 years and mean marriage length was 17.8 
years, indicating that many of the women became married in their late teenage years. An 
explanation for the 11% difference between men that are currently married and those that live 
with their wives was articulated in the qualitative data and is explained later in this chapter.  
In terms of education, this group attended a mean of 7.3 (SD=3.9) years of schooling, 
with 10.8% illiteracy and 22% completing school through grade 10. In terms of employment, 
92.5% were reported holding a job. Slightly more than half (51.8%) were employed in private 
business, while others worked in petty businesses such as food stands, or paan shops, (13.6%). 
Daily wage earning, often in the form of strenuous labor, was reported by 12.5% of the sample, 
and 10% were employed as drivers or mechanics. The median monthly income for their 
households was 10,000 rupees, or approximately US $150. A median was reported because of a 
small percentage (1.4%) of high incomes over Rs 50,000 that skewed the mean.  
Of the sampled married men, 126 (42.3%) had wives that were currently HIV positive, 
while 8.1% of the men were unaware of their wives’ HIV status. Of the wives that were known 
to be HIV-positive, 71% were concurrently receiving ART. Out of 129 men who responded to a 
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question regarding the HIV status of other family members, 15.5% indicated having an HIV-
positive child, 1.1 % had a positive brother, and 0.6% had a positive mother.   
In-Depth Interview Demographics 
 The mean age of the 55 men who contributed in-depth interviews to the AIM project was 
39.3 years, with an age range extending from 22 to 55. Forty-eight, or 87.2% of this group were 
either currently or previously married, with an average marriage length of about 15 years.  
Among the 42 men with children, they have an average of 2.3 offspring, identical to the survey 
group.  Six of the men were widowed at some point in their lives, with three of them knowing 
that the cause of their wife’s death was from HIV infection. Sixteen, or 38% of the currently 
married men have partners that are HIV positive, and three have HIV positive children.  
The average monthly income for IDI sample was 11500 rupees, or approximately US 
$173. Also slightly higher in the IDI group was the average number of years in education at 8.6, 
with two indicating that they hold college degrees. Despite reporting greater amounts of income 
and education than the survey population, the percentage that were employed at the time of 
interview was slightly lower, at 89%.  The ethno-religious distribution of the interview group 
was similar to those who participated in the survey, with the majority of those interviewed 
considering themselves Hindu (74.5%), followed by Buddhist (12.7%), and Muslim (7.2%). This 
distribution is similar to the survey group, with the addition of two Christians and one man who 
was Jain.   
Characterizing Internal Stigma  
Table 2 includes the Likert-scale results from each of the 16 component questions that 
comprise the scale. The histogram in Chart 1 demonstrates visually the distribution of Internal 
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Stigma scores, ranging in this sample from a minimum mean of 1.0 (minimal to no feelings of 
internal stigma) to a maximum of 4.0 (The highest level of internal stigma). The sample mean for 
the scale was 2.58 (SD = 0.55, Skewness = 0.26) signifying that the entire group trends toward 
some feelings of internalized stigma. The reliability of the internal stigma scale was high, with a 
Cronbach’s Alpha score of .89.   
Table 2 
Internal Stigma Scale Component-Statement Percentage Results (n=361). 
 
Paraphrased Statement from Survey Strongly Disagree Disagree Agree 
Strongly 
Agree 
In many areas of life, no one knows I have HIV 
 11.1 17.5 32.1 39.3 
Telling someone I have HIV is risky 
 9.4 11.9 37.2 41.4 
People with HIV lose jobs when employers find 
out 
 
12.2 27.1 35.5 25.2 
I work hard to keep my HIV a secret 
 8.6 18.1 45.6 27.8 
I feel I am not as good a person compared to 
others 
 
11.9 38.2 33.5 16.3 
I am very careful who I tell about my HIV 
 4.2 14.1 52.9 28.8 
Most people believe a person with HIV is dirty 10.8 42.9 28.5 17.7 
Having HIV makes me feel unclean 9.7 33.0 42.7 14.7 
I worry that people may judge me if they knew 
my status 
 
5.0 19.9 42.4 32.7 
Hurt by people’s reaction to knowing my status 
 16.7 47.9 19.8 15.6 
I regret having told some people about my 
status 
 
17.5 48.9 21.1 12.5 
People I care about stopped calling after 
learning my status 
 
19.8 53.5 14.5 12.3 
I have stopped socializing with some due to 
their reactions 
 
17.6 53.6 20.1 8.7 
People don’t want me around their children 
 19.7 59.7 12.1 8.5 
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People who know my status tend to ignore my 
good points 
 
16.4 38.4 34.0 11.1 
I have lost friends telling them of my status 
 20.7 47.8 20.7 10.9 
  
        Chart 1. Distribution of Internal Stigma Scale Scores (n=361) 
 
The results of Table 2 and Chart 1 indicate that issues surrounding disclosure of one’s 
HIV status are the most commonly reported negative perceptions or experiences in this sample of 
HIV-positive men. Over 70% of respondents either agreed or strongly agreed with five 
statements directly regarding disclosure. Three of these statements relate to general actions taken 
by the individual to protect their disease status from being widely known: “In many areas of life, 
no one knows I have HIV” (71.4% agree), “I work hard to keep my HIV a secret” (73.4% agree), 
and “I am very careful who I tell about my HIV” (81.7% agree). The other two statements are 
perceptions or beliefs about disclosure: “Telling someone I have HIV is risky” (78.6% agree) and 
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“I worry that people may judge me if they knew my status” (75.1% agree). The men tended to 
disagree with statements probing for specific negative actions that have occurred to them 
because of the disclosure of their HIV status, fearing negative reactions rather than actually 
experiencing them as enacted stigma. The statement “People with HIV lose jobs when employers 
find out” is an example of anticipatory stigma to which 60.7% of the men agreed, “Most people 
believe a person with HIV is dirty,” is another to which nearly half agreed (46.3%). This form of 
stigma is another anticipatory perception rather than an actual lived experience. Finally, two 
statements were aimed at directly identifying instances of guilt: 49.8% agreed that “I feel I am 
not as good a person compared to others,” and 57.3% agreed that “Having HIV makes me feel 
unclean.” These final two statements relating to self-directed blame and guilt adhere closely to 
how the occurrence of internal stigma was articulated throughout the qualitative data. 
Qualitative Characterization of Internal Stigma  
 The interview data provides a diversity of internal stigma expressions, ranging from 
serious mental illness coupled with the danger of self-harm, to very positive and optimistic 
outlooks on the individual’s health and emotions. Common to all discussion of internal stigma 
across this spectrum were themes of self-directed guilt and blame for their current status as 
PLHIV. The primary pattern of internal stigma was associated with regret for past encounters 
with sex workers, which was the likely source of their infection with HIV.  
My present condition is because of that habit [of visiting sex workers]. I am thinking, 
“Why did I go to that side [the Red light district]?”  If I didn’t go to that side, I should not 
need this treatment. (Age 38, Single, No Children) 
I feel sad, because I am responsible for my problem. If I didn’t go to Kamathipura Red 
light district for sex, this problem would not have happened to me…it is a shame for me, 
because it is my fault. (Age 35, Married, 2 Children) 
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A thought come into my mind, Why I did I have a sexual relation? [with a sex worker] 
Then I repent for my mistake. But now what do I do? I have done mistake. (Age 35, 
Married, 2 Children) 
 
The qualitative data included some examples of more extreme forms of internal stigma 
intensity. Here, indicators of internal stigma, namely, self-directed guilt, anger, and fear were 
directly cited as contributing to the suicidal tendencies by some of the men. In the examples 
below, both men are single with no family. 
Then I came back to home, whenever I was alone I was feeling worried about my status; I 
was feeling guilty that I have done a big mistake in my life. I was having tension. 
Negative thoughts were coming in to my mind. I was thinking of suicide.                        
(Age 33, Single, No Children) 
Sometimes I got angry on myself. I always ask the question to myself, what I did? And 
how you will face to the society? But I knew this is happened because of me. But I have 
fear of society. And I have guilt also. And sometime I feel to finish myself.                      
(Age 36, Single, No Children) 
  
On the other end of the internal stigma continuum, some individuals expressed positive or 
optimistic perceptions of their experience with HIV. When specifically asked about aspects of 
internalized stigma such self-blame or guilt, individuals who followed a pattern of positive 
coping felt that it was wrong to direct blame at themselves or anyone else. Also notable was the 
frequent connection these men made to these positive emotions and the improvement of their 
adherence to ART medications and their current and long-term health outcomes.  
I don’t regret my illness. As I told you, I don’t want to take any tension. I want to live my 
life with joy and happiness. If I do this, then it will increase one year of my life.            
(Age 38, Married, No Children) 
I take medicines on time, I eat on time, I have non veg food at the hotel where I work 
almost every day, I take proper sleep, I do not think much about my illness, I try to be 
happy every time, and I do not worry much about my death. So I think this helps me to 
improve my health. (Age 36, Single, No Children) 
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No I am not blaming my luck on another person…So I am not taking any type of tension. 
One thing is that I always remember that I have this disease and I should take medicine 
and food proper. (Age 42, Married, 2 Children) 
 
 Additional direct expressions of self-guilt and self-blame were found across the 
qualitative data and are included in the following sections as narrative examples of the 
associations found in the multiple regression analysis.  
Factors Associated with Internal Stigma 
Twenty-one variables were used to explore the associations of a series of independent 
variables with the internalized stigma scale using standard multiple regression analysis (Table 3). 
The model accounted for 39.1%, or 35.3% when adjusted for overestimation, of the variance 
found in the Internal Stigma scale (R=.625, R2=.391, R2adj=.353, F (21,339) =10.369, p < .001). 
None of the resultant Tolerance scores were below the collinearity cutoff threshold of 0.1. 
Descriptive statistics for all variables used in the regression model are included in Table 4. 
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Table 3 
Results from the Standard Multiple Linear Regression Analysis (“Enter” Method) for factors 
associated with the Internal Stigma Scale (n=361). 
 
Independent Variables B β t Sig. Bivariate R* 
Collinearity 
Tolerance 
Depression Scale 1.361 0.278 5.443 < .001*** .465*** 0.69 
External Tenshun Scale -0.189 -0.196 -3.649 < .001*** -.424*** 0.62 
Network of Positive People 
(NMP+) Support Scale 0.584 0.198 3.206 0.001*** -.164*** 0.47 
NGO Support Scale -0.880 -0.197 -3.294 0.001*** -.225*** 0.50 
Family Support Scale -0.186 -0.118 -2.359 0.019** -.156*** 0.72 
External Stigma Scale -0.563 -0.109 -2.161 0.031** -.286*** 0.70 
Reasons for Drinking Scale -0.277 -0.119 -2.154 0.032** -.360*** 0.59 
ART Center Support Scale -0.489 -0.101 -2.059 0.040** -.236*** 0.743 
 
Variables that did not significantly contribute to the Standard Multiple Regression model: Mean Number of 
STIs†, Alcohol Use (AUDIT Scale), General Health, Food Insecurity Scale, Quality of Life Scale, Length of ART 
Use (Years), Time since HIV Diagnosis (Years), Education Level, Age, Friend Support Scale, ART Adherence 
(4-Day), Family-Related Tenshun Scale, ART Adherence (30-Day) 
 
Note: ***p < .01, **p < .05;  
* Bivariate R value is a Pearson’s Correlation with the Internal Stigma Scale;  
†” Mean Number of STI” scale was found to be significant in the subsequent Stepwise Multiple Regression 
model 
 
Eight of the independent variables significantly contributed to the standard regression 
model at, or below, the .05 Alpha level. The CES depressive symptom scale, External Tenshun 
Scale, PLHIV scale, and the NGO Support Scale were found to be significant at the p < .01 level. 
The Family Support Scale, External Stigma scale, Reasons for Drinking scale, and ART Center 
Support Scale were significant at the p < .05 level. None of the variables related to demographics 
were found to contribute to the model, including age, education level, years since HIV diagnosis, 
and years since ART initiation. Likewise, four- and 30-day ART adherence, AUDIT Scores, and 
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the General Health, Quality of life, Food insecurity, Family-related tenshun, and Friend Support 
scales failed to reach significance as predictors of internal stigma. The  
To determine the relative importance of these significant variables independent of the 
others, a stepwise multiple regression analysis using the “backward deletion” method was 
performed. This method removes independent variables from the original 21-variable model in a 
staggered fashion until only the significant predictors remain. The results of this second 
regression model (shown in Table 6) demonstrated that nine key variables predicted 37.6% (or 
36% when adjusted) of the Internal Stigma scale variance (R=.613, R2=.376, R2adj=.360, F 
(9,351) =23.517, p < .001).  All eight variables found to be significant in the Standard Multiple 
Regression were also found to be significant in this Stepwise model, with the addition of Mean 
Number of STIs (β= -0.104, p= .025). The remaining 12 independent variables together were 
associated with only 1.5% (Standard R2=.391 minus Stepwise R2=.376) of the variance in the 
outcome of Internal Stigma. 
Of note, the stepwise multiple regression model placed a measure of the presence of 
sexually transmitted infection as a significant factor associated with internal stigma. This 
association suggests that facing more co-occurring STI diseases symptoms such as genital ulcers, 
genital warts, swelling in the groin, urethral discharge, or pain upon urination is associated with 
higher levels of internalized stigma. While other indicators of sexual risk behaviors were not 
included in this analysis, such a significant finding warranted further analysis of the connection 
between past or present risky sexual behavior and internal stigma in the qualitative data. The 
specific relationship between STIs and stigma was not well articulated in the qualitative data, but 
the discussion of guilt surrounding risky sexual behavior and the use of sex workers shown 
above was considered proxy topic for this association. 
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The eight significant variables in the regression have been grouped into three categories 
based on the similarity of their subject matter and overlapping themes found in the IDI data. The 
ordering of these categories roughly approximates the order of statistical significance found in 
Table 2, with aspects of mental health (depression, tenshun, and alcohol use) discussed first, 
followed by the influence of social and organizational support from Families, NGOs, and ART 
centers. Finally, the relationship between internal stigma and external stigma has been separated 
into its own category for analysis. 
Mental Health Status 
Issues of mental health and alcohol use were among the strongest factors that contributed 
to the regression model. First, there was a significant positive relationship between the CES-
Depression scale and Internal Stigma, such that an increased level of depression was associated 
with a more negative internalized stigma. A significant relationship was also found between the 
External Tenshun scale and the dependent measure such that greater experience with tenshun 
was associated with greater internal stigma. Reasons for Drinking was also associated with the 
Internal Stigma Scale such that that more reasons for drinking was paired with greater 
internalized stigma.   
Several themes emerged from the interview data regarding the relationship between 
mental health and internal stigma, generally beginning with strong emotional responses to the 
individual’s initial HIV diagnosis. Great variation was noted in these initial reactions. On one 
end of the response spectrum, a small group (3) demonstrated a feeling of expectation and 
acceptance of the news. This reaction seemed to concur with their understanding the risks of 
their current or past lifestyles. These men three spent time as young adults drinking and visiting 
commercial sex workers.  
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I took it easy (Mi ekdam shantpane ghetale!). Before getting the reports I was mentally 
prepared for the results. I had told myself that let the report be positive, I am not going to 
collapse. (Age 32, Married, 1 Child) 
I knew it that HIV can happen to anybody. Nobody can say it confidently that it cannot 
happen to him or her. When I had my friends around me who were HIV positive, I had 
realized that I have also been maintaining the same life style as they were, so I am also at 
the risk of acquiring it, sometime or the other in life. (Age 45, Married, 2 Children) 
I was bit shocked, but I was knowing that it could happen. Her face (the sex worker with 
whom he had sex) was ringing in my mind. (Age 44, Married, 3 Children)  
 
The majority of men (34) indicated a general feeling of shock, loss, tension, confusion, or 
fear upon receiving their diagnosis, forming the primary pattern of emotional reaction found in 
the sample. Some men specifically said that the news brought immediate sadness or depression.  
When I was diagnosed HIV positive, I was in tension, having stress because of my illness. 
I was feeling so sad about my status, I thought that now I have very few days to live.                     
(Age 35, Married, 2 Children) 
I was depressed for many days because of that reasons and got more depressed once I 
finally learned that I was HIV positive. (Age 38, Married, 3 Children) 
And when I got the report of my HIV, then I was in depression. I was talking with myself 
only, I hadn’t talked with anyone else. Four months I hadn’t talked with a single person, I 
was sitting in my house only and crying, talking with only myself. Those days were worst 
days in my life. I was confused and totally blank. (Age 35, Married, No Children) 
 
There were eleven men who said that they had, or continue having thoughts about 
suicide. Several stated that they actually attempted suicide or came very close. For two of them, 
this mental status existed prior to their HIV diagnosis; the rest arrived at this mental state as the 
after effects of diagnosis overwhelmed their lives with stressors and guilt. 
Yes, I was tensed. That time doctor asked me, “What you are going to now?” I replied, 
“Madam, you tell me what to do.” That time I was feeling like stepping in front of the 
train, or hanging myself. I was wondering what I should do to end my life.                       
(No Age Indicated, Married, 1 Child) 
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Now days I don’t feel like living anymore…I have experienced. Every living being dies 
one day or the other. If we are living, then I will die and it is for sure. I know I am 
suffering from this disease. So why should die with pain? (Age 38, Married, No Children) 
 
Feelings of self-guilt, self-blame, or personal shame were expressed throughout the 
interviews, most often in relation to their fear of disclosure and the resulting negative responses 
they believe could follow release of personal information. Many indicated feelings of profound 
and continuous stress or tenshun stemming from this fear.  Most of the men did not disclose 
beyond their wives and close relatives for fear of damaging their standing in society and the 
reputation of their entire family. There were only a few examples of disclosure to trusted friends 
or to their employers. Eight of the respondents had shared their status with their wives 
exclusively, while only two said that they had not disclosed their status to anyone.  
First thing is fear in my mind, as I didn’t share with anybody that I am HIV positive. If 
anybody comes to know, it will be not good for me. (Age 35, Married, No Children) 
It is a bad disease. Cancer and other diseases are much better than HIV. Other diseases 
don’t create any bad name. But this creates a very bad image in family and society. (Age 
52, Married, 2 Children) 
 
 Another fear was that of losing their source of income once friends and others in the 
community learn of their HIV status. Both of the examples below do not mention experiencing 
actual discrimination nor do they mention hearing vicariously about specific act of stigma 
against other positive people.  
Then there is risk of losing my job. Also, I have to face the torture and agony of the 
world (duniya ki nafarat!). Everybody in the world will come to know about it. They will 
say, “Look at this ‘famous man’! He has ‘this disease’!” Thus they will look down upon 
me. They may not say these things in front of me, but certainly they will say these things 
on my back that this fellow has HIV. (No age indicated, Married, 1 Child) 
I am feeling scared of being HIV positive; if someone comes to know about my status 
then I have to close my shop.  No one will take Paan from me. I will not able to survive 
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among friends. I cannot eat together with friends. Hence I sometimes feel very negative. 
(Age 35, Married, 2 Children) 
 
 There were many examples of drinking as a coping mechanism that arose across the 
qualitative data. The patterns described below involved drinking as a way to forget or ignore the 
guilt and stress of being HIV positive. This HIV-related guilt, in addition to fears about the 
wellbeing and support of their family in the future provided reasons for alcohol consumption that 
were pervasive throughout the qualitative data.  
I want to forget about my HIV, and I always think about my family. I pray to the god for 
my long life. Because I have to take care of my family, these things always come in my 
mind. I drink to forget these things. (Age 41, Married, 2 Children) 
When I am feeling tense, that time I drink alcohol. I try to ignore the situation when 
there is tension, stress and guilt feeling, sometimes I cry when I become emotional. Most 
of the time I try to ignore negative feelings and tension, but if that tension increase, then 
I go alone in the bar and drink alcohol. (Age 33, Single, No Children) 
 
The guilt was so strong that I used to have maximum amount of alcohol until I attain 
profound sleep. Again after getting up, I used to drink a lot. I felt like ending my life this 
way. I never wanted to be in a state of consciousness. I started withdrawing from others. 
I never felt like having food. The whole day I used to drink and sleep at home. I never 
felt like going out or meeting friends, too. (Age 38, Married, 1 Child) 
 
An alternative to the pattern of mental health issues, alcohol use, and internalized stigma 
outlined in the quotes in this section are the descriptions of positive coping methods found in 
some of the interviews that indicate less feelings of internalized stigma. A common form of 
positive coping was a general expression of optimism and forward, future-based thinking, often 
referring to the desire to survive for their children and families.  
However, I do not think more about my illness, I don’t like having tension and stress. 
Now I only think that to take care for family, my mother and father, and to educate my 
son for his good future, to keep my family happy (Ghrchyana sukhi thevayache).  HIV 
positive people taking tension, I don’t like that. This patient should not take tension of 
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having HIV illness, “Tension mansala marun takte” (tension kills the patient!). He 
should think about his future life and family. (Age 31, Married, 1 Child) 
I have no fear of death. I have no guilt for what I did in past. If my death is fixed this 
way, no one can change it. I am only worry for my wife and son. I want to be alive and 
healthy till my son grew. (Age 32, Married, 1 Child) 
 
Social Support 
The next group of significant relationships found in the multiple regression models 
related to various avenues of potential support, or lack of support, received by the men. The 
Network of Positive People (NMP+) scale measures the amount of support received specifically 
by the Network of Maharashtra People with HIV NGO. There was a significant positive 
relationship between the NMP+ scale and Internal Stigma such that less NMP+ support was 
associated with higher scores on the internal stigma scale. A similar association was found 
between our dependent measure of internal stigma and support from other NGOs. The significant 
relationship between lack of organizational support and greater feelings of internalized stigma 
continued with the ART Center Support Scale. At the level of the family, a significant 
association with Internal Stigma was found with the Family Support Scale. The questions that 
comprise the NGO, ART, and Family support scales refer to receiving assistance in a variety of 
realms, including ART adherence and medical treatment, psychological and emotional needs, 
financial support, informational and legal support, and in participation with social networks or 
programs.  
The regression analysis indicated a significant association between family support and 
internal stigma among the study population, such that individuals with greater amounts of 
support demonstrated less internalized stigma. It was clear from the qualitative data that support 
from spouses was the most essential form of family support for the men’s overall well-being, 
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particularly in the realm of emotional and moral support, as well as with assistance in ART 
adherence and supplying medication from ART centers.  
She is my life (owh meru jaan hai). I am surviving because of her. (Mai sirf uski wajah 
say jinda hun).  She takes care of me, gives me food on time, medicine on time, manages 
household expenses, and the children’s education with limited money. She never argues 
with me because of my HIV infection. In fact, she is still not understanding the severity of 
this problem. (Age 38, Married, 3 Children) 
My wife gives me moral support; she is concern about my illness. She used to say that if 
you getting well then we will do everything for children and family.                                 
(Age 35, Married, 2 Children) 
She stood beside me in my bad days. When I was depressed and wanted to die, she took 
charge of my life. She said not to worry. She assured that she is there with me forever. 
(Age 51, Married, 2 Children) 
 
While most of the married men indicated a positive relationship with their wives, there 
were a few examples of negative spousal relationships, with five indicating fighting or some 
form of domestic violence. While most men did not describe reactions to initial spousal 
disclosure as anything beyond shock, sadness, and support, some wives reacted to the news in a 
negative way, placing blame and shame onto their husband. The connection between such 
immediate, enacted stigma from wives could be a facilitator of internalized stigma  
My wife and my brother-in-law fired on me. My wife told me that you went out for sex 
and this is the result (tumne bahar jakar ganda kaam kiya usi ka natija hai ye). “How 
you get these disease?” They blame me a lot that you are not good person. Why you get 
married if you are having this kind of diseases? You are cheater, you are not good 
person, and you are bewda (drinker) and so many things. I will not excuse you.           
(Age 53, Married, 1 Child) 
 
Relating to the difference between those currently married (82.5%) and those actually 
living with their wives (71.5%) found in the quantitative data, eight of the married men 
interviewed lived separately from their wives after their HIV diagnosis (17%). Most of these 
involved the wife returning to her natal family village home, yet the exact reasons for (and 
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lengths of) all of these separations varied between tension and fighting in the household and a 
desire to protect children and other family members from the disease. 
Lots of fighting and discussion were held in that night in my house… My wife decides 
that she will not going to stay with me. She has left home along with daughter went to 
her native place. That time my daughter was just 2 years old. I was in big tension. (Age 
53, Married, 1 Child) 
 
I don’t know, I told you I stayed with her only two months in two years. She is staying in 
village and I am staying here. I go to village after long period. I didn’t like village that’s 
why not going frequently. My mood not allowing to me go to village.                                    
(Age 35, Married, No Children) 
 
One way it is good that I am here and she is at native. This way there is no opportunity 
for sex and infection to her. (Age 35, Married, 2 Children) 
 
In one case, a man did not reveal the fact that he had contracted HIV from a sex-worker 
until an undisclosed amount of time later. In this case, the wife returned to her native home 
specifically for fear of societal stigma. 
But I didn’t disclose my sexual relation with sex worker in initial days. Later I told 
her…My wife asked me, “How it happened?” and blamed me that I am responsible for 
my ill health and putting all family in to dark…My wife is more concerned. She said if 
people know, they will neglect us from village and society. (Age 52, Married, 2 Children) 
  
 Instances of wives living separately from their husbands for fear of HIV infection or any 
perceived shame the diagnosis brings upon the family can be considered forms of enacted or 
external stigma directed at the men in the sample, thus there is significant overlap between 
spousal support and external stigma.  
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Beyond the marital relationship, support from other family members was also very 
important in addressing tension, depression, and HIV-associated guilt. Such support after 
disclosure to family may be protective against development of internal stigma. Directly below 
are examples of this beneficial relationship.  
I didn’t felt much bad, because all my relatives were with me. They were support me. 
They know about it, so I didn’t get any tension. Now I have my mother, father, and 4 
children at my home. One daughter got married and one is enough grown for marry. I 
have lot of support from them. I am earning okay, so there is not much tension in my life. 
My all relatives know about me and my HIV problem. (Age 42, Married, 4 Children) 
My family is very cooperative, my friends also know about my status, so I never spent a 
time alone. Hence I do not feel bad.   I enjoy every moment even I am HIV positive. Also I 
do not feel guilty myself. (Age 51, Married, 4 Children) 
So I started taking medicines in front of all. I think I am getting love from all. Today my 
son was asking me whether I need him to accompany me to the ART center. I felt very 
good when he asked me this. (Age 48, Married, 3 Children) 
 
Given the prominence of familial support for the well-being of these men, it follows that 
lack of support or expressions of enacted discrimination originating from family members could 
have a magnified negative effect. These experiences seemed to have the most negative effect on 
their mental health, internalized stigma, and welfare.  
Sometimes I feel guilty, sometimes negative thoughts come in to mind. Most of the time 
my family (brothers) have spoken very badly. So I don’t want to meet them even I don’t 
want to talk with them, since I am not feeling well as I was in past. Sometimes I blame on 
myself, why do I did this test? When my brother came to know about my status he asked 
me to leave the home, I was left there, I had no place to stay, and sometimes I used to 
sleep on the road. (Age 33, Single, No Children) 
We were living together few years back, but since HIV was diagnosed to me, my brothers 
asked me to live separate. My parent wish to live with me, but my bothers don’t allow 
them to live with me. They said my HIV status is creating bad name and image in family 
and relatives. Slowly it will start negatively impact on my child once they will know my 
HIV problems. They asked me to live alone. (Age 32, Married, 1 Child) 
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 Like the negative actions of spouses in reaction to the HIV status of their husband, 
discriminatory behavior originating from other family members demonstrates further overlap 
between the lack of family support and external stigma. The most common examples of external 
stigma found in the interviews were initiated by the men’s extended family. In the next section, 
other aspects of external stigma are shown.  
Direct support from ART center staff seemed to be very important for individuals in 
getting beyond feelings associated with internalized stigma, as best seen in the quotes below. 
This could be because of a higher level of trust when such support comes directly from 
authoritative figures such as the ART center doctors. These examples were not ubiquitous in the 
interviews, but the majority of the men indicated an overall positive experiences with their ART 
center.  
Initially, when I came to know that I am HIV positive I felt ashamed of myself. I thought 
that the whole world will come to know about this. Even when I went to the hospital I was 
feeling very awkward to ask anybody where the ART center is located. But fortunately, 
those around me who know it are taking every effort to save my life.                                          
(Age 51, Married, 2 Children) 
I was in big tension. My thinking power was finished and not understating what to do and 
what to not do. The doctor gave me solace and said many people are living with this 
disease. Don’t worry everything will become normal. Doctor has suggested to me to start 
the medicine from another doctor. This doctor is very much familiar to me.                                                 
(Age 45, Married, No Children) 
 
 An additional supportive function of ART centers that addressed some aspects of internal 
stigma was simply the sight of many other positive people seeking treatment. This made some 
men feel as if they were not alone in their struggle and seemed to improve their emotional status 
and overall outlook on life.  
After HIV diagnosis, I was hopeless for life.  But once I saw many HIV patients in these 
centers, I got encouragement for survival. (Age 32, Married, 1 Child) 
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But when I visited the ART center then I saw I am not alone who is living with HIV. I 
come every month and see the patients more than 30, and they feel good. And it is more 
important to feel good. And I also feel good, because they also got the same treatment 
which I had taken from the doctors and counselors. (Age 38, Married, 1 Child) 
 
The primary pattern found in the qualitative data to explain the association between NGO 
support and internal stigma seems to be that positive, supportive interactions with NGOs and 
ART centers that were described improved their outlook, reduced tension, and gave men a more 
optimistic perception of their illness.  
Finally, in terms of NGOs, when men were asked about their knowledge or involvement 
with them, many said that they had seen NGO representatives at ART centers, but had not sought 
or received any help from them, or that they have never been approached by NGO 
representatives. Some men conveyed negative experiences or beliefs about NGOs for a variety of 
reasons such as lack of time, lack of need, or non-follow-up, as demonstrated in the quotes 
below. 
There is some people who stand outside of the ART center. One day they told me about 
the government schemes and then they told me to show my green card. I denied them. 
And told them I don’t want to fill any form and I don’t want any support. I am earning 
and I don’t like to waste my time. (Age 44, Married, 3 Children) 
Till today I haven’t received any benefit from NGO. I have given them my documents 
and my form was also filled by them. They were talking about a pension scheme, under 
that scheme I was supposed to get money. But I haven’t received money yet. (Age 47, 
Married, 1 Child) 
They are not doing work for the patients. They create more tensions for us. They fill up 
their records only; they are not providing any help to the patients. They are asking only 
who is your father is who is your mother? Taking only information from us for our work. 
What is meaning talking to them? It is wasted of time to talk them. You are doing your 
own work, let me do my work. (Age 42, Married, 4 Children) 
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There were, however, important positive experiences described in regards to the support 
offered by NGOs. The support described was largely emotional, providing a venue for discussion, 
education on leading a healthy life, and group counseling. Such support could be protective against 
the development of internalized stigma. 
When we go there, then they treat us very nicely. And there are lots of HIV positive 
patients who come for the prayer. And they also know (staffs of the NGO), they can’t 
cure us, but they want to see the smile on patients face. And if patients have some 
problems in their life then they share with the staffs of NGO.                                            
(Age 41, Married, 2 Children) 
They had explained many cases, how they survive and living healthy since 25 years of 
HIV diagnosis. I got encouragement to live healthy by learning these examples.                 
(Age 55, Married, 3 Children) 
These NGO people are doing noble job. They are providing love and support. The ART 
staff is also very good. (Age 38, Married, 3 Children) 
 
Two of the men had successfully utilized an NGO service that connected men with HIV 
positive women for marriage. As demonstrated in another section, wives are the most important 
figure in many men’s lives in terms of social and emotional support, as well as for health support 
with adherence to ART. 
I came to know my wife through SATHI project (a NGO working with HIV people at an 
ART center). I was HIV positive since birth, therefore I was knowing that no one fresh 
(non-HIV positive) would marry with me. While visiting the ART Center I understand 
that SATHI project staff are helping people like us to get marry with HIV positive if both 
are agreeing. They (SATHI project staff) learned about me and my family while filling a 
form. They told me about my wife that she also from Nepal. They help me to meet my 
wife in his Dharavi NGO project office. (Age 22, Married, No Children) 
 
External Stigma 
The External Stigma Scale demonstrated a significant association with Internal Stigma in 
the multiple regression model, such that more experience with discrimination directed towards 
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the men because of their HIV status is associated with greater Internalized stigma. Actions by 
family members followed by enacted discrimination in the workplace were the most common 
types of external stigma mentioned. Some manifestations of these types of external stigma 
include withholding payments for completed work and withholding opportunities further 
employment due to their HIV status.  
My transport office is not giving me job. They have not paid my full dues. They are 
saying, “Not much work is here now.” They are saying, “You are on treatment, therefore 
driving is not good for me at present.” (Age 44, Married, 3 Children) 
The Supervisor did not say anything beyond, “Get tested properly. Take your medicines.” 
After that I went to my village. When I returned from my village a few days later, then I 
was suspended from work.  (Age 49, Married, 2 Children) 
 
Since most of the men have not disclosed their HIV status beyond close family members, 
there were limited examples of external stigma at the community level. In two of the prominent 
cases that were shared, the occurrence of mistreatment from strangers seems to instill self-
directed guilt and blame.  
They serve me separately or hesitate to use bathroom after I use it. They generally tell me 
to have my meal before them. Everybody is aware that HIV does not spread this way. But 
it is their right to protect their health first. I feel very sorry for that. But somewhere I feel 
that they are right. (Age 27, Single, No Children) 
However, the place where I work there is one fellow who is aware about my status; he 
often visits my Paanshop. Yesterday he was come in the evening and he had drunk 
alcohol, so he was using abusive language using my name. Hence I was feeling sad, and 
felt hurt. I used to blame on myself for that. Because of that big mistake people are 
behaving with me badly. (Age 35, Married, 2 Children) 
 
Living in a large urban area like greater Mumbai may instill some anonymity in people’s 
lives, helping them avoid local disclosure and discrimination that may be more common in 
smaller village settings.  
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I had a very good relationship with my neighbor at my native place. Once they knew my 
HIV, they stopped coming my home and also stopped talking with me. My children were 
teased in schools. People and other student say that his father is an HIV patient. It was 
difficult for children to cope with that situation. It is not only with me; it was with many 
other people at my native. The village was small, such things can’t be hidden… I have not 
disclosed my HIV status here in Mumbai. (Age 55, Married, 3 Children)  
 
Below are examples of vicarious stigma in which PLHIVs hear stories of discrimination 
or personally observe how other people with similar circumstances are treated, leading to their 
own internalized fear of stigma and disclosure.  
I have seen how others behave with positive people. In past, there was one man at my 
work place who was HIV positive. Now he is no more. Everybody knew that he was 
positive. They used to avoid talking to him. But in his absence people used to talk about 
his sexual life in a cheap manner. They used to make fun of him. When I got infected I 
decided to keep my illness to myself and not to discuss about it to anybody else.                                        
(Age 35, Married, 2 Children) 
People hate us. Last month I heard about someone with HIV who died. Till the last 
moment, people refused to touch him. For this reason, I began to worry that people who 
find out would discriminate against me. (Age 49, Married, 2 Children) 
 
Interrelationships between Factors 
The qualitative results in this chapter have demonstrated close affiliations among the 
variables shown through the multiple regression model to be individually associated with 
expressions of internal stigma. For instance, a significant contributor to HIV-related depression 
and tenshun was the fear of experiencing external forms of stigma. This stigma, when enacted or 
imagined, could be on a more immediate level from one’s family or workplace, or on a broader 
level from one’s community or society at large. In terms of support, we see its close relationship 
with mental health in the emotional benefits of support from either spouses, other family 
members, or from organizations. Alternately, we see the emotionally destructive effect of 
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deficient support or enacted stigma from these figures in the men’s lives.  Through all of the 
interconnecting factors that affect an individual’s mental health and perception of their illness, 
patterns of self-blame, shame, and guilt emerge as our primary indicators of internal stigma 
expression.  
Figure 2. Path Analysis for Regression Model as Suggested by Qualitative Data. 
 
 Figure 2 demonstrates a suggested path analysis of the variables found to be significantly 
associated with internal stigma in the standard multiple regression analysis (Table 3). Although 
the research for this thesis was cross-sectional, this approximated path analysis was suggested by 
the qualitative results and would require a longitudinal study for confirmation. The origin of a 
general pattern towards the development of internal stigma was experience with or fear of 
external stigma. This real or perceived experience with stigma was paired with tenshun and 
anxiety, which for some contributed to reasons for consuming alcohol and symptoms of 
depression. Social support from family, NGO, and ART Centers then acted as mediators in this 
path. The lack of support from these areas, with particular emphasis on practical and emotional 
support from immediate family members, led to expressions of internal stigma (self-blame, 
shame, and guilt) given the presence of previous mental health issues.  
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Chapter Five - Discussion & Conclusion 
 From a broad perspective, the outcomes of this research have demonstrated the mental 
health consequences of dealing with a permanently life-altering disease. These consequences 
stem from the interaction of both internal and external forces, particularly the relationships 
among how an individual perceives their illness, what coping strategies they use to deal with its 
effects, and the quality and variety of social support that they can access. In light of the results, 
the presence of high internal HIV stigma may influence all of these forces in a negative way, 
ultimately leading to decreased ART adherence, accelerated morbidity, and the further spread of 
HIV. External stigma perceived and/or expressed by family, healthcare workers, community 
members, or institutional policy inherently obstructs the delivery of social support that is critical 
to positive health and mental health outcomes for patients on HIV treatment. Real or perceived 
stigma from such sources may lead to additional depression and anxiety, mental states that are 
commonly expressed after initial diagnosis with HIV. Experiences with external stigma and the 
resultant impact on mental health may influence an individual’s own perception of their illness, 
an internalization of stigma characterized by stigma acceptance, guilt, and self-directed blame 
and shame for their disease status. 
The results of this thesis indicate a strong relationship, both qualitatively and 
quantitatively, between internalized stigma and mental health status among the sampled male 
population who consume alcohol and are on antiretroviral therapy in urban Maharashtra. The 
primary pattern indicated that self-directed blame, shame, and guilt regarding HIV status, paired 
with greater expressions of depression, tenshun, and reasons to consume alcohol was associated 
with greater internal stigma. The qualitative data indicated that this association was often set in 
place very soon after HIV diagnosis and that fear of enacted stigma following disclosure was the 
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most common vehicle for immediate and continued mental distress. The close relationship 
between internal stigma and mental health status confirms the initial hypothesis and supports 
much of the existing literature on HIV stigma across different international contexts, including 
India.  
At the other end of the continuum, PLHIV with lower internal stigma expressed the 
ability to overcome feelings of self-blame through techniques that could be identified as positive 
and adaptive coping strategies. The techniques used by some of the men included an optimistic 
and future-oriented mindset that did not dwell on or feel guilty about past risky behaviors. This 
way of thinking allowed for some to focus on ART adherence, stress avoidance, and healthy 
living as a path toward a normal spent with family and friends. Feelings of social responsibility 
to protect others from infection and finding a sense of community among other people living 
with HIV also accompanied positive coping.   
A major additional finding from this analysis was the quantitative relationship between 
social support from families, NGOs, and ART Centers and internalized stigma. The qualitative 
results indicated that support from these sources positively impacted men’s mental health status 
and was associated with avoidance of self-blame for their HIV status. Of all sources of social 
support, support from family, and in particular spouses, was found to have the most influence on 
mental health and successful outcomes with ART adherence.  
There was an expected relationship between internal and external stigma, with the most 
damaging form of external stigma seemed to originate from family members. This phenomenon, 
along with the generalized fear of external stigma in the absence of directly experiencing it, 
limited disclosure, which in term limited support.  
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Interventions Addressing HIV Stigma  
 Stigma-focused intervention projects have been increasing in both number and scope, 
with more studies involving PLHIV directly and taking place at multiple levels (group, 
community, institutional). However, many efforts to reduce both external and internal stigma  
must address the deficiencies in past programs that include: lack of sustainability, limited 
evaluation of effectiveness; a narrow focus on individual level HIV education for prevention of 
enacted stigma; and lack of proper attention or measurement on internalized forms of stigma 
(Bharat, 2011; Mahajan et al., 2008; Sengupta, Banks, Jonas, Miles, & Smith, 2011; Stangl et al., 
2013).  
Internal Stigma & Mental Health-Related Interventions  
An independent search of existing literature and the content of four HIV-stigma literature 
reviews conducted since 2008 yielded only two studies that specifically focused on interventions 
for internalized stigma. One study by Rao et al. (2012) adapted the HIV Stigma Toolkit 
developed by ICRW for use in small population (N=24) of HIV-positive female African-
Americans. Across two workshops, groups of women viewed “triggering” videos about HIV 
discrimination and then shared and discussed personal coping strategies they have used to deal 
with the effects of real or perceived stigma. A role-playing portion of the intervention guided the 
women through dealing with difficult situations triggered by stigma. A pre-and post-assessment 
of engagement and internal stigma feelings showed an overall acceptance of the methods and a 
measured reduction of stigma (Rao et al., 2012). Another intervention recruited a sample of 
female PLHIV from an urban area in the southern United States to pilot test the Integrated Model 
of Health Promotion through “Emotional Writing Disclosure” activities. The writing focused on 
the psychological effects of HIV diagnosis and the internalization of stigma feelings. The model 
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that was successfully piloted in this study aimed for cognitive re-organization and improved 
psychological, physical, and behavioral health outcomes (Abel, Rew, Gortner, & Delville, 2004). 
 While few interventions have specifically addressed internal stigma, more have used a 
broad focus on improving mental health among PLHIV. In both Uganda and Zambia for 
example, home-based counseling and testing programs showed success integrating psychosocial 
support, counselling for individuals and couples, community mobilization, and health education 
in reducing HIV stigma and improving both status disclosure and ART adherence (Jürgensen, 
Sandøy, Michelo, & Fylkesnes, 2013; Nuwaha, Kasasa, Wana, Muganzi, & Tumwesigye, 2012). 
On a more systemic level, recommendations for the early integration of mental health treatment 
into HIV care through collaborative teams have been proposed due to the high prevalence and 
morbidity of psychological disorders among PLHIV that directly prevent treatment success and 
HIV control (Kaaya et al., 2013; Prince et al., 2007). 
For the most part, interventions in India have not addressed internal stigma directly, 
although it has been examined and encouraged by Steward et al. (2008) through the creation of 
four stigma surveys that measured enacted, vicarious, felt-normative, and internalized stigma in 
the context of India. Another study with PLHIV in the context of South India explored positive 
coping strategies such participation in positive networks and maintenance of family well-being to 
deal with stigma, particularly the fear of being labeled “immoral” (Kumar, Mohanraj, Rao, 
Murray, & Manhart, 2015). 
Social Support-Related Interventions 
 One of the major gaps found among existing HIV stigma interventions is a lack of 
evaluation on the lasting impact of stigma reduction on social support among PLHIVs (Sengupta 
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et al., 2011). Of the few existing stigma interventions relating to social support, many have 
focused on high risk populations such as female sex workers and injection drug users (Knowlton, 
Hua, & Latkin, 2004; Qiao, Li, & Stanton, 2014). In Nigeria, mass media educational campaigns 
were demonstrated to successfully improve individual PLHIV’s perception of social support 
availability (Fakolade, Adebayo, Anyanti, & Ankomah, 2010). In Uganda, collective activities to 
challenge stigma and the use of peer support groups for the delivery of HIV services and 
treatment was demonstrated to foster social support among PLHIV and reduce community 
stigma levels (Mburu et al., 2013).  
Family-involved HIV stigma interventions were found to be very rare despite a 
recognized need to address the problem based on evaluations of stigma’s impact at the family 
level, including in the Indian context (Bharat, 2011; Bogart et al., 2008). One study determined 
the viability of a psychoeducational intervention between serodiscordant couples that addressed 
depression, anxiety, perceived social support, and spousal stigma (Gordon-Garofalo & Rubin, 
2004).   
External Stigma Interventions 
 Globally, the most common type of HIV stigma interventions have attempted to address 
the issue at an individual level, primarily targeting healthcare workers and students with 
education about HIV to decrease the fears and misconceptions that lead to discriminatory beliefs 
and enacted stigma (Bharat, 2011; Stangl, Lloyd, Brady, Holland, & Baral, 2013).  In LMICs, a 
common form of stigma intervention has been utilizing mass media campaigns to distribute HIV 
education or situational narratives aimed at reducing levels of community-level stigma, to which 
some success was demonstrated (Fakolade, Adebayo, Anyanti, & Ankomah, 2010; Mahajan et 
al., 2008). 
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 Interventions addressing external stigma at higher, systemic levels such as organizational 
and public policy often require significantly more resources and political leverage. In a review of 
stigma interventions, only 10% of studies were focused on these levels with negligible evaluation 
efforts (Stangl et al., 2013). One of the most damaging sources of HIV discrimination globally 
comes from punitive laws and policies that criminalize HIV non-disclosure or the transmission 
of HIV. Such laws are in place in more than 100 countries, codifying and reinforcing stigma 
within societies (UNAIDS, 2015b). In the United States alone, over half of all legal jurisdictions 
have such punitive laws in place. Suggested policy changes to diminish or abolish such laws 
include the wide adaptation of harm-reduction policies and the modernization of existing statutes 
to remove criminal penalties (Lazzarini et al., 2013). 
Many of the same issues identified with previous stigma-reduction interventions have 
been replicated in India, particularly with negligible efforts at evaluation and a general lack of 
interventions aimed at multiple levels. Likewise, the most common method of past interventions 
in India focused on behavior change of individual nurses or other health care workers with the 
goal of reducing fear and discrimination through education (Bharat, 2011). While this form of 
intervention may be important, the commonality of healthcare-associated stigma calls for more 
organizational or systemic-level projects.  
Addressing Stigma in the RISTHA/AIM Project 
The intervention phase of the RISTHA/AIM project includes individual, group, and 
community-level activities. These different levels are all are aimed at reducing alcohol use and 
increasing ART adherence among PLHIV, while simultaneously addressing a range of 
biopsychosocial factors that impact adherence such as mental well-being, social support, and 
stigma.  
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Individual Level 
At the individual level, ART center counselors received training to utilize the Solution 
Focused-Narrative Intervention Model with participants during one-on-one sessions. This 
counseling model allows participants to identify a problem, set goals for themselves, identify 
personal strengths and weaknesses for addressing the problem, and then utilize and build on 
existing strengths to reduce the problem. Over the course of four sessions, issues of relationships, 
tenshun, alcohol use, adherence, and status disclosure are addressed. An assessment of internal 
stigma and disclosure is given before the first topic session. Internalized stigma is incorporated 
during the session on disclosure after the participant relays his personal story of sharing or not 
sharing his HIV status with others. The benefits and consequences of both disclosure and non-
disclosure are discussed before a personal disclosure plan developed. Internal stigma, depression, 
and lack of social support as a result of non-disclosure is pointed out, and improved mental 
health paired with greater support is mentioned as a benefit.  
RISTHA/AIM intervention activities at the individual-level relate to the results of this 
thesis by focusing specifically on the mental health effects of non-disclosure and generating 
techniques to overcome personal fears over the perceived aftermath of sharing one’s HIV status. 
A generalized fear of experiencing stigma following disclosure was found in the qualitative data 
to be a significant source of mental health distress and connected to acceptance of stigma 
through self-blame, shame, and guilt. The direct measurement of baseline internal stigma levels 
using a scale further addresses issues that arose in this thesis regarding gaps in the literature and 
past interventions that did not focus on or acknowledge stigma internalization.  
Group Level 
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At the group level, facilitators from NMP+ and RISTHA staff run four sessions regarding 
healthy living strategies, tenshun, relationships, and alcohol’s impact on ART adherence. These 
sessions are intended to produce both individual and group-level outcomes. In the healthy living 
portion, group participants learn that stigma and disclosure are some of the things that are linked 
with alcohol use and adherence, and that positive thinking is a strategy for maintaining health. 
During the relationships session, participants learn that self-stigma can negatively affect 
relationships and social support through activities that have groups map out the size and quality 
of their social networks both before and after diagnosis. A portion of the relationship session 
further stresses the significance of reciprocity for maintaining key relationships and for 
developing new social connections in the men’s lives. Positive coping strategies and their 
connection with general health are also discussed in the session on tenshun, including improving 
family relationships, avoiding risky habits such as drinking, and seeking out support from 
counselors or Positive People networks. The group sessions end by connecting all of the topics in 
a framework that collectively affect each other and ultimately the outcome of ART adherence.  
 The highlighted group-level intervention activities regarding positive coping methods for 
healthy living and tenshun-reduction directly connect with the results of this thesis. These 
techniques were identified as ways some men overcame the mental health effects of living with 
HIV and rejected the feelings of self-imposed blame, shame, and guilt comprising internal 
stigma. Incorporating the importance of relationship maintenance into the group meetings also 
links to the present research findings that point to multiple sources of social support as a vital 
part of ART adherence and positive mental health. Working with participants to then list and find 
solutions to issues within key life relationships, the focus will likely be on spouses and 
immediate family members. The results of this thesis found that family members serve opposite 
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functions in terms of social support; they are the most important source of practical and 
emotional support, as well as the primary source of external stigma. 
Community Level 
At the community level, larger groups of 15-20 participants living in same general area 
are gathered and assessed for their perception of and experience with stigma in their shared 
community. Intervention activities begin with discussions about human rights issues in relation 
to their experience as PLHIV and about forms and uses of collective action. The group then 
works collectively to identify a solvable issue in their community that contributes to stigma, 
discuss its causes, and determine what realistic outcomes they could hope to achieve through 
their collective voice and action. After planning and practicing their action plan, it is actually 
implemented and then self-evaluated by the group. The overall goal of the community level 
intervention is to target social isolation of PLHIV by getting them to achieve a goal through 
collective work in a public setting, demonstrating the prospect of change in the way PLHIV are 
treated and recognized publically.   
Specifically addressing the harmful social isolation of PLHIV caused by real or perceived 
external stigma through collective action relates the RISTHA/AIM community intervention with 
the results of this thesis. Quantitatively and qualitatively, experience of external stigma and fear 
of its occurrence was associated with greater internal stigma, perpetual mental distress, and non-
disclosure of HIV status. The social isolation that results from these fears directly impacts the 
willingness to seek practical and emotional social support from different sources, a key form of 
positive coping. The collective action used in this intervention to enact realistic change may also 
be beneficial in getting at any feelings of hopelessness and depression among participants that 
nothing can be done about stigma at higher levels.  
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Suggestions for Further Interventions 
The results of this thesis have suggested several openings for intervention at multiple 
levels to address the effects of internalized stigma. First, the profound psychological effect of 
receiving an HIV diagnosis was well-demonstrated. The majority of men interviewed indicated 
feeling high levels of anxiety, shock, depression, and in several cases, suicidality, that was 
expressed concurrently with personal shame and guilt for behaviors that may have led to their 
HIV infection. Thus, addressing perceptions of stigma as early as possible may be critical to 
avoid its later internalization. It is suggested that stigma-focused counselling sessions occur 
within the first two ART Center appointments after referral from an ICTC. Through these initial 
counselling sessions, assessment and discussion about the effects of stigma could occur with 
follow-up for problematic cases upon subsequent monthly visits the ART Center. At this stage 
there may be value in educating patients about the relatively low prevalence of community 
discrimination that nonetheless elicits much fear and distress in the population. This could be 
paired with the promotion of physical and psychological benefits of status disclosure and the 
generation of personal support systems.  
Given internal stigma’s close relationship with depression and tenshun, repeated 
expressions of shame and guilt should be evaluated and addressed as a mental health issue within 
the context of individual or group-level counseling at ART Centers during patient’s monthly 
visits. Follow-up sessions should focus on the impact of guilt, blame, self-imposed anger, and 
hopelessness. These topics could be discussed along with introducing the idea of HIV as a 
manageable disease and that the avoidance of internalized stigma and the use helps to improves 
health outcomes and social relationships. While it was demonstrated in this thesis that patients do 
not always have adequate time for interactions with counseling staff at ART Centers, current 
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guidelines should be changed to include some content or staff training the expressions of HIV 
stigma and its effects. Patients should be periodically assessed for the presence of external and 
internal stigma, utilizing the aforementioned stigma measurement tools adapted for India by 
Stewart et al. (2008). Specific methods to challenge internal stigma should be based on teaching 
positive thinking and adaptive coping strategies. Looking to the Solution Focused-Narrative 
Intervention Model used by the RISTHA/AIM project in their individual-level intervention, 
people who report frequent internalized stigma, an activity could be utilized that allows patients 
to identify their own sources of guilt, shame, and blame and develop personalized strategies 
based on personal strengths to address them. 
The relative commonality and negative impact of external stigma within the context of 
families was well demonstrated in this population and warrants serious attention. Extensive 
research is needed to better assess and investigate the pervasive yet hidden nature of familial 
stigma that may perpetuate it as something felt as normative (and therefore internalized) in the 
Indian population. Further, the direct positive effects of family support on mental health status 
and ART adherence build the case for proposing a family-level HIV-stigma intervention. Since 
families are composed of many inter-relationships between individuals and between groups of 
individuals, as well as existing as distinct units itself (“close” family & “extended” family), 
intervention activities within the families ideally would have multiple levels.  
Individual members could first be assessed for stigma beliefs and the level of social 
support they provide the family member with HIV. The positive family member would be 
assessed for both experiences with external stigma from other family members and the extent to 
which stigma has been internalized. Individual counseling and education sessions could be used 
to identify and address negative beliefs held by family members and convey the importance of 
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supporting the positive member in terms of their physical and mental health outcomes. 
Intervention in the marital unit would be essential given the importance of this relationship for 
all aspects of successful HIV care. Based on efficacious intervention research involving 
heterosexual couples aimed at reducing sexual risk behavior in the context of Mumbai (Kostick, 
Schensul, Singh, Pelto, & Saggurti, 2011) and the United States (El-Bassel et al., 2003), couples’ 
stigma counseling may involve topics such as communication, problem solving skills, and 
negotiation to address shaming and guilt, building beneficial and emotionally supportive 
relationships. Finally, multiple family members could be gathered as a unit for a stigma 
intervention to facilitate positive coping, mutual trust, and family support. This may be achieved 
by targeting specific expressions and effects of stigma through a narrative role playing or group 
performance technique, similar to those presented at a community level by NACO. Future 
research and intervention on family-level stigma may be a highly effective means of reducing the 
harmful individual and public health effects of internalized stigma in the context of India. 
Conclusion 
Living with HIV, managing a lifelong course of ART medication and consuming alcohol, 
men in this study are adapting to life in a variety of positive and negative ways that are 
dependent on their personal perception of the illness and the sources of support accessible to 
them. Through a mixed methods analysis of interrelated organizational, social, behavioral, and 
psychological factors, this thesis has demonstrated the pervasive influence of stigma in their 
lives. The close affinity between the internalization of stigma, the negative mental health 
consequences, and poor coping strategies calls for making internalized stigma a key aspect of a 
comprehensive and holistic HIV treatment program. This thesis has identified two empirically-
based strategies, early psychological counseling to reduce internalized stigma and engagement of 
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spouse and other family members to reintegrate the PLHIV into familial support. It is the hope of 
the author that this study can make a small contribution both to the effectiveness of ART Center 
programs and the lives of people with HIV.  
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Tables 
Table 4 – Descriptive Statistics for all Independent Variables Used in the Standard 
Multiple Regression (n=361). 
Dependent Variable Mean Standard Deviation Skewness Range 
Cronbach
’s Alpha 
Internal Stigma Scale 2.58 0.55 0.25 1 – 3.88 .89 
Independent Variables Mean Standard Deviation Skewness Range 
Cronbach
’s Alpha 
Age 41.53 8.70 0.17 21 – 66 -- 
Education Level 7.32 3.94 -0.35 0 – 17 -- 
General Health 1.05 0.22 4.02 1 - 2 -- 
External Stigma Scale 1.94 0.10 -2.74 1.37 - 2 .79 
NMP+ Scale  1.82 0.18 -0.62 1.32 - 2 .85 
Family Support Scale 1.47 0.34 0.07 1 -2 .91 
Friend Support Scale 1.87 0.17 -1.59 1.09 - 2 .75 
NGO Support Scale 1.93 0.12 -2.40 1.36 - 2 .73 
ART Support Scale 1.87 0.11 -2.08 1 - 2 .57 
Food Insecurity Scale 1.86 0.30 -2.08 1 - 2 .91 
Quality of Life Scale 1.27 0.31 1.25 1 - 2 .73 
CES-Depression Scale 0.32 0.11 1.52 .09 - .77 .69 
30-Day Adherence 0.54 0.49 -0.16 0 - 1 -- 
Family-Related 
Tenshun Scale 2.89 1.69 1.81 1 - 9 .82 
External Tenshun Scale 1.80 0.57 0.40 1 - 3 .80 
AUDIT Scale 8.15 5.67 1.18 1 - 35 .77 
Reasons for Drinking 
Scale 1.57 0.23 -0.39 1 - 2 .52 
Co-Occurring STI 
Scale 1.91 0.14 -2.21 1.11 - 2 .66 
4-Day ART Adherence 0.91 0.24 -3.29 -0.5 - 1 -- 
Years on ART 3.85 2.40 0.94 .58 - 15 -- 
Years Since HIV 
Diagnosis 5.00 3.42 1.36 .58 - 22 -- 
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Table 5 – Pearson’s Correlational Matrix among primary variables (n=361). 
Variables Internal Stigma        
Depression  
(CES-D) 0.47** CES-D       
External 
Tenshun  
(EXT) 
-0.42** -0.39** EXT      
Reasons for 
Drinking (RD) -0.36** -0.29** 0.45** RD     
External Stigma 
(EXS) -0.29** -0.15** 0.35** 0.30** EXS    
NMP+  -0.16** -0.16** 0.32** 0.35** 0.23** NMP+   
Family Support 
(FS) -0.16** -0.04 0.18** 0.27** 0.11* 0.21** FS  
NGO Support 
(NGO) -0.23** -0.18** 0.11** 0.13* 0.13* 0.57** -0.11* NGO 
ART Support 
(ART) 0.24** -0.21** 0.11** 0.19** .02 0.23** -0.07 0.37** 
Note: *p< .05; **p< .01 
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Table 6 - Results from the Stepwise Multiple Linear Regression Analysis (“Backward 
Deletion” Method) for predictors of Internal Stigma (n=361). 
Independent Variables B β t Sig. 
Depression Scale 1.418 0.290 6.137 < .001** 
External Tenshun Scale -0.207 -0.215 -4.128 < .001** 
PLHIV Scale 0.580 0.197 3.400 0.001** 
NGO Support Scale -0.875 -0.196 -3.469 0.001** 
Family Support Scale -0.179 -0.113 -2.434 0.015* 
External Stigma Scale -0.551 -0.107 -2.262 0.024* 
Reasons for Drinking Scale -0.259 -0.112 -2.165 0.031* 
ART Center Support Scale -0.467 -0.097 -2.078 0.038* 
Mean Number of STIs -0.407 -0.104 -2.247 0.025* 
Note: *p < .05, **p < .01 
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Appendix 1 – RISTHA / AIM In-Depth Interview Coding Guide 
Domain Factor Explanation 
Logistics  Screening, setting up the interview, finding 
a location, number of sessions, availability 
of time, any mention of interruption during 
the case intake  
Appearance  Clothes, cleanliness, degree of strength or 
frailty, (aversion) willingness to respond, 
any sign of depression/ anxiety, speech 
evaluation, comfort, eye contact  
Health Status Pre-diagnosis First symptoms of HIV, onset of the 
problem, symptoms noticed for the first time 
 Post diagnosis Within 6 months, degree of disease 
progression, improvement 
 Current Symptoms and complaints, any mention of 
current ailment, medication side-effects, 
opportunistic infections, co-morbidities  
 CD4 counts Trajectory, procedure of testing, initiation of 
treatment. Delays-in and recommendations-
for treatment based on CD4 counts from 
physicians. 
 TB Any mention, diagnosis and treatment  
Alcohol Pre-diagnosis Life story of alcohol use 
 Post-diagnosis Immediate response (6 months) in-terms 
increase use of alcohol,  
Changes to drinking after learning HIV+, 
justification given by patients for his use of 
alcohol 
 Current Pattern of drinking behavior, types of 
alcohol, activities associated with alcohol 
use 
ART Medication Schedule When and how they take the medication 
 Adherence  Description of adherence and misses in 
taking medication, justification in missing  
 Storage Where the respondent keeps the medication, 
how they transport it 
 Support Individuals who remind the respondent to 
take the medication, other person collecting 
medicines on patient’s behalf, 
permission/leave granted by the employer 
 Initiation  Anything relating to the start of treatment, or 
lack thereof.  
 Side Effects Anything related to physical side effects of 
ART medication 
ART Centers  General Respondents use of ART services, the 
evaluation of the services, complaints, 
medication availability, any other challenges 
in receiving services, awareness or lack of 
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awareness of services offered at ART center, 
distance, transfer from other centers, 
comparison among multiple ART centers, 
cooperation and real or perceived barriers to 
services, any suggestions to improve the 
services  
 Medical Care Medical treatment/advice from physicians 
received at ART center, mention of MOs and 
SMOs 
 Record Keeping Maintaining record of respondent’s 
medication schedule on White Card & Green 
Book 
 Counseling  Counseling from ART center staff about 
HIV details, nutrition, adherence, mental 
issues 
 Pharmacy/Medication ART Center process of dispensing 
medication 
 Group Meetings Mention of ART Center offering group 
counseling sessions and/or education to 
patients 
Work  Lifelong history of work including pre- and 
post-diagnosis, voluntarily discontinuation 
of job, switching over the career, 
unemployment, nature of work,   
Household dynamics  Who lives with the respondent, the nature of 
the interaction, other HIV+s in the 
household, stressors, triggers to use alcohol 
derived from household; anxiety related 
family future, conflict within family. 
Interpersonal interactions within the 
household. 
Extended family  Both Husband and Wife’s family, 
awareness/support/ stigma by extended 
family 
HIV etiology  Source of infection, including not knowing, 
personal attribution of the HIV infection as 
an attempt to conceal the real cause 
Diagnosis  Description of diagnosis of HIV 
Diagnosis response  Immediate, ongoing, and evolving response 
to the news; beliefs, denial and acceptance, 
sharing, and trauma 
Wife  Non-sexual aspects of relationship, 
communication, blame for HIV, violence, 
support, ignorance,  
Emotional status  Current tension (tenshun), stress, depression, 
anxiety, coping strategy,  
Finances ART Expenses  Costs for travel, other medications, time 
away from job, any other prescribed tests, if 
patient buys privately in case of shortage of 
medicine  
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 Income/other expenses Sources, his own and family income, debt, 
loan, mortgage   
Tobacco  Smokeless tobacco, cigarettes, beedi, 
gutkha, any addiction to Paan or any other 
tobacco habit 
Friends  Individuals in the respondent’s social 
network and activities in which they 
participate, their role in their use of alcohol 
or seeking the treatment 
Social support  Which people and what supports for money, 
transport, support of the family, picking up 
of medication (other than family members), 
emotional support who provide, availing of 
government scheme benefits. In regards to 
respondent’s personal network, not support 
from the ART Center.  
Disclosure  Who has the respondent told, who else 
knows, who suspects, 
Decision to disclose the status, immediate 
reaction of that person 
Nutrition  All mention of food including counselor 
advice, family member advice and cooking, 
food scarcity, his own belief about the diet, 
any change in the dietary plan, limitations in 
following the prescribed diet 
Stigma Internal Self-blame, guilt, lack of self-respect or 
positive attitudes, any self-harm, aversion to 
socialization, any mention of phobia or the 
lack thereof. 
 External Rejection and reactions from medical 
personnel, community members, friends, 
family, co-workers or positive reactions 
from these sectors 
NGO involvement  There are NGOs and the Positive Peoples’ 
Network that work with the ART services 
for referral, support and tracing those “lost to 
follow-up.” Respondents can be members, 
give services to others and be a beneficiary 
of services. Also includes NGO activities 
(Street performance, posters, education) 
Childhood/adolescence  Life history and details of growing up 
Other Treatments  Medications (e.g. over-the-counter, 
Ayurvedics), visits to private doctors 
(allopathic, Ayurvedics, unani, homeopathy, 
naturopathy), pooja and prayers and other 
alternative approaches, exercise/ Yoga, 
attending prayers or accepting/ changing the 
religion  
Sexual Behavior Wife Marital sexual relationship, decision to have 
children, abstinence  
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 Other partners Regular or causal relationships with partners 
other than spouse, high risk behavior, visit to 
CSW 
 Condom use Any mention of use of condoms pre or post 
diagnosis, awareness/ counseling about use 
of contraceptive 
HIV Knowledge  Information and misinformation on 
treatment, etiology, transmission etc. 
Excludes how they believe they became 
infected.  
Children  Including grandchildren, voluntary or forced 
withdrawal from children 
Residence  Mention of current or past residence or 
community, location   
Social Responsibility  Concern for not infecting others, concern for 
the well-being of others involved  
Desire Marriage&Children    Any pressure to marry, any desire to marry 
on the part of single or widowed men 
AlcoholReasoning  Answers to the question: why do men drink 
alcohol? 
Negative Coping  Any coping behaviors with negative 
physical, mental, or social consequences: 
Examples include drinking, suicidal 
thoughts, feelings of guilt/isolation, anger, 
feeling ashamed, anxious 
Positive Coping  Any positive behaviors to cope with illness: 
connecting/finding community with other 
HIV+ people, prayer/religion, positive & 
future thinking, social responsibility to 
protect others & keep living, benefits of 
status disclosure, focus on nutrition & 
exercise, seeking support form others, taking 
pride in work 
Adherence_Alcohol  Any description of how they adhere to the 
ART medication despite the fact that they 
still use alcohol 
Non-Adherent_Alcohol  Any description of how alcohol use negative 
affects adherence to ART medication, ex. 
Skipping/missing doses when drunk 
Non-Adherent_Other  Any description of skipping/missing doses 
of ART for reasons other than alcohol. Ex. 
Work, cannot pick up medication, vacation, 
travel, lack of reminder  
Wife HIV Status  Any mention of the HIV status (positive, 
negative, or unknown) of the current or 
former wife of the interviewee. 
Sexual-Domestic Violence  Any mention of sexual violence or domestic 
violence against any family member.  
 
